Electrovaya (ELVA) 6-K/A 17 Dec 24 Current report (foreign) (amended) Financial data

Cover

Cover	12 Months Ended
	Sep. 30, 2024
Cover [Abstract]
Document Type	6-K/A
Amendment Flag	true
Amendment Description	Explanatory Note   We are amending our Report of Foreign Private Issuer on Form 6-K originally furnished to the U.S. Securities and Exchange Commission on December 13, 2024 (the “Original Filing”), solely for the purpose of (i) providing the audited consolidated financial statements contained therein with the relevant Interactive Data Files in Inline XBRL format and (ii) including Form 52-109F1 certifications of our Chief Executive Officer and Chief Financial Officer as Exhibits 99.4 and 99.5, respectively. As such, other than the foregoing, no part of the Original Filing is being amended.
Document Period End Date	Sep. 30, 2024
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2024
Current Fiscal Year End Date	--09-30
Entity File Number	001-41726
Entity Registrant Name	Electrovaya Inc.
Entity Central Index Key	0001844450
Entity Incorporation, State or Country Code	Z4
Entity Address, Address Line One	6688 Kitimat Road
Entity Address, City or Town	Mississauga
Entity Address, State or Province	ON
Entity Address, Postal Zip Code	L5N 1P8

Consolidated Statements of Fina

Consolidated Statements of Financial Position - USD ($) $ in Thousands	Sep. 30, 2024	Sep. 30, 2023
Current assets
Cash and cash equivalents	$ 781	$ 1,032
Trade and other receivables	11,292	10,611
Inventories	9,698	8,266
Prepaid expenses	7,647	5,997
Total current assets	29,418	25,906
Non-current assets
Property, plant and equipment	9,202	10,149
Long-term deposit	862	459
Total non-current assets	10,064	10,608
Total assets	39,482	36,514
Current liabilities
Trade and other payables	9,460	8,420
Working capital facilities	16,283	11,821
Promissory notes	519	1,026
Short term loans	1,630	3,457
Derivative liability	155	1,489
Relief and recovery fund payable	13	9
Lease liability	471	389
Total current liabilities	28,531	26,611
Non-current liabilities
Lease liability	1,871	2,338
Government assistance payable	152	96
Other payables	343	323
Total non-current liabilities	2,366	2,757
Equity
Share capital	116,408	115,041
Contributed surplus	10,904	9,249
Warrants	4,725	4,725
Accumulated other comprehensive income	5,792	5,890
Deficit	(129,244)	(127,759)
Total Equity	8,585	7,146
Total liabilities and equity	$ 39,482	$ 36,514

Consolidated Statements of Earn

Consolidated Statements of Earnings - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Profit or loss [abstract]
Revenue	$ 44,615	$ 44,059
Direct manufacturing costs	30,926	32,203
Gross margin	13,689	11,856
Expenses
Research and development	3,038	3,382
Government assistance	(316)	(387)
Sales and marketing	2,935	1,897
General and administrative	3,939	3,687
Stock based compensation	2,155	1,167
Depreciation and amortization	1,209	907
Operating expenses	12,960	10,653
Income from operations	729	1,203
Net finance charges	2,366	2,474
Foreign exchange loss (gain) and interest income	(152)	887
Loss before income tax	(1,485)	(2,158)
Deferred tax recovery		679
Net loss for the year	$ (1,485)	$ (1,479)
Basic and diluted income (loss) per share	$ (0.04)	$ (0.04)
Weighted average number of shares
Outstanding, basic and fully diluted	34,012,383	33,832,784

Consolidated Statement of Compr

Consolidated Statement of Comprehensive Income (Loss) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Profit or loss [abstract]
Net loss for the year	$ (1,485)	$ (1,479)
Items that will not be reclassified to Profit and Loss
Gain on revaluation of property (net of deferred tax)		1,921
Items that may be reclassified to Profit and Loss
Cumulative translation adjustment	(98)	525
Other comprehensive income (loss) for the year	(98)	2,446
Total comprehensive income (loss) for the year	$ (1,583)	$ 967

Consolidated Statements of Chan

Consolidated Statements of Changes in Equity - USD ($) $ in Thousands	Share Capital [Member]	Contributed Surplus [Member]	Warrants [Member]	Accumulated Other Comprehensive [Member]	Deficit [Member]	Total
Balance – October 01, 2023 at Sep. 30, 2022	$ 103,305	$ 8,099	$ 4,725	$ 3,444	$ (126,280)	$ (6,707)
IfrsStatementLineItems [Line Items]
Stock-based compensation		1,167				1,167
Issuance of shares	7,306					7,306
Exercise of options	17	(17)
Exercise of warrants	4,413					4,413
Revaluation of property				1,921		1,921
Cumulative translation adjustment				525		525
Net loss for the year					(1,479)	(1,479)
Balance – September 30, 2024 at Sep. 30, 2023	115,041	9,249	4,725	5,890	(127,759)	7,146
IfrsStatementLineItems [Line Items]
Stock-based compensation		2,155				2,155
Issuance of shares	169					169
Exercise of options	1,198	(500)				698
Cumulative translation adjustment				(98)		(98)
Net loss for the year					(1,485)	(1,485)
Balance – September 30, 2024 at Sep. 30, 2024	$ 116,408	$ 10,904	$ 4,725	$ 5,792	$ (129,244)	$ 8,585

Consolidated Statement of Cash

Consolidated Statement of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Operating activities
Net loss for the year	$ (1,485)	$ (1,479)
Amortization	1,209	907
Stock based compensation expense	2,155	1,167
Interest expense and other financing charges	2,339	2,474
Non-cash foreign exchange	(40)	1
Gain on debt extinguishment	(936)
Bad debt expense / recovery	51
Premium on purchase of SEJ		495
Deferred tax recovery		(679)
Cash provided by operating activities	3,293	2,886
Net Changes in the working capital	(2,255)	(8,121)
Cash from (used in) operating activities	1,038	(5,235)
Investing activities:
Purchase of property, plant and equipment	(125)	(505)
Change in long term deposits	(541)	(398)
Cash used in investing activities	(666)	(903)
Financing activities
Issuance of shares		7,167
Issuance of warrants		3,259
Exercise of options	131	21
Exercise of warrants		3,004
Proceeds from working capital facilities	52,247	35,727
Repayment of working capital facilities	(47,805)	(34,184)
Repayment of vendor take back loan	(1,879)	(750)
Repayment of promissory note		(4,945)
Interest and other finance cost	(2,533)	(2,011)
Government assistance	(55)	(28)
Lease payments	(735)	(707)
Cash from (used in) financing activities	(629)	6,553
Increase (decrease) in cash and cash equivalents	(257)	415
Cash and cash equivalents, beginning of year	1,032	626
Effect of movements in exchange rates on cash held	6	(9)
Cash and cash equivalents at end of year	781	1,032
Supplemental cash flow disclosures:
Interest paid	2,233	1,793
Income tax paid

Reporting Entity

Reporting Entity	12 Months Ended
	Sep. 30, 2024
Reporting Entity
Reporting Entity	1. Reporting Entity Electrovaya Inc. (the “Company”) is domiciled in Ontario, Canada, and is incorporated under the Business Corporations Act (Ontario). The Company’s registered office is at 6688 Kitimat Road, Mississauga, Ontario, L5N 1P8, Canada. The Company’s common shares trade on the Toronto Stock Exchange and NASDAQ under the symbol ELVA.TO and ELVA, respectively. The Company has no immediate or ultimate controlling parent. These consolidated financial statements comprise the Company and its subsidiaries (together referred to as the “Group” or “Company”). The Company is primarily involved in the design, development, manufacturing and sale of Lithium-Ion batteries, battery systems and battery-related products for energy storage, clean electric transportation, and other specialized applications.

Basis of Presentation

Basis of Presentation	12 Months Ended
	Sep. 30, 2024
Basis Of Presentation
Basis of Presentation	2. Basis of Presentation a. Statement of Compliance These consolidated financial statements have been prepared based on the principles of International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”) and the Interpretations of the International Financial Reporting Interpretations Committee (“IFRIC”). The consolidated financial statements have been prepared on a historical cost basis, except for property, plant and equipment and derivative financial instruments that have been measured at fair value. These consolidated financial statements were authorized for issuance by the Company’s Board of Directors on December 12, 2024. b. Basis of Accounting These consolidated financial statements have been prepared on the going concern basis, which contemplates the realization of assets and settlement of liabilities as they fall due in the normal course of business. During the year ended September 30, 2024, the Company generated cash from operations of $ 1.04 5.23 0.89 0.71 1.49 1.48 c. Functional and Presentation Currency These consolidated financial statements are presented in U.S. dollars and have been rounded to the nearest thousands, except per share amounts and when otherwise indicated. The functional currency of the Electrovaya Inc. is the Canadian dollar and the functional currencies of the all the Group’s companies is US Dollars. Below are the companies within Group - Electrovaya Corp., Electrovaya Company, Sustainable Energy Jamestown LLC, Electrovaya USA Inc. d. Use of Judgements and Estimates The preparation of the consolidated financial statements in conformity with IFRS requires management to make judgements, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses. Actual results may differ from these estimates. Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimates are revised and in any future periods affected. Information about significant areas of estimation uncertainty that have the most significant effect on the amounts recognized in the consolidated financial statements relate to the following (assumptions made are disclosed in individual notes throughout the consolidated financial statements where relevant): ● Estimates used in determining the net realizable values of inventories, taking into account the most reliable evidence available at each reporting date. The future realization of these inventories may be affected by future technology or other market-driven changes that may reduce future selling prices. ● Estimates used in testing non-financial assets for impairment including determination of the recoverable amount of a cash generating unit. ● Estimates used in determining the fair value of stock option grants and warrants. These estimates include assumptions about the volatility of the Company’s stock and forfeiture. ● Deferred tax assets are recognised for unused tax losses to the extent that it is probable that taxable profit will be available against which the losses can be utilised. Significant management judgement is required to determine the amount of deferred tax assets that can be recognised, based upon the likely timing and the level of future taxable profits, together with future tax planning strategies. Information on tax losses carried forward is presented in Note 24. Allowance for expected credit losses The allowance for expected credit losses is based on the assessment of the collectability of customer accounts and the aging of the related invoices and represents the best estimate of probable credit losses in the existing trade accounts receivable. The Company regularly reviews the allowance by considering factors such as historical experience, credit quality, the age of the account receivable balances, and current economic conditions that may affect a customer’s ability to pay. Stock-Based Compensation The Company account for stock-based compensation costs in accordance with the accounting standards for stock-based compensation, which require that all stock-based payments to employees be recognized in the audited consolidated statements of earnings based on their fair values. The fair value of stock options on the grant date is estimated using the Black-Scholes option-pricing model using the single-option approach and the Monte Carlo valuation method depending on the type of option granted. The Black Scholes and Monte Carlo option pricing models require the use of highly subjective and complex assumptions, including the option’s expected term and the price volatility of the underlying stock, to determine the fair value of the award. Warrants The Company accounts for warrants in accordance with the accounting standards for warrants, which requires all warrants to be recognized in the audited consolidated statement of financial position based on their fair values. The fair value of warrants on the grant date is estimated using the Black-Scholes pricing model approach. The Black Scholes pricing model requires the use of highly subjective and complex assumptions, including the warrant’s expected term and the price volatility of the underlying stock, to determine the fair value of the award.

Material Accounting Policies

Material Accounting Policies	12 Months Ended
	Sep. 30, 2024
Material Accounting Policies
Material Accounting Policies	3. Material Accounting Policies The accounting policies below are in compliance with IFRS and have been applied consistently to all periods presented in these consolidated financial statements. a. Basis of consolidation i. Subsidiaries These consolidated financial statements include direct and indirect subsidiaries, all of which are wholly owned. Any subsidiaries that are formed or acquired during the year are consolidated from their respective dates of formation or acquisition. Inter-company transactions and balances are eliminated on consolidation. Subsidiaries are entities controlled by the Company. The financial statements of subsidiaries are included in the consolidated financial statements from the date that control commences until the date that control ceases. The accounting policies of subsidiaries have been changed when necessary to align them with the policies adopted by the Company. All subsidiaries have the same reporting dates as their parent Company. ii. Transactions eliminated on consolidation Intra-company balances and transactions, and any unrealized income and expenses arising from intra-company transactions, are eliminated in preparing the consolidated financial statements. b. Foreign currency Each subsidiary of the Company maintains its accounting records in its functional currency. A Company’s functional currency is the currency of the principal economic environment in which it operates. i. Foreign currency transactions Transactions carried out in foreign currencies are translated using the exchange rate prevailing at the transaction date. Monetary assets and liabilities denominated in a foreign currency at the reporting date are translated at the exchange rate at that date. The foreign currency gain or loss on such monetary items is recognized as income or expense for the period. Non-monetary assets and liabilities denominated in a foreign currency are translated at the historical exchange rate prevailing at the transaction date. ii. Translation of financial statements of foreign operations The assets and liabilities of subsidiaries whose functional currency is not the U.S. dollar are translated into U.S. dollars at the exchange rate prevailing at the reporting date. The income and expenses of foreign operations whose functional currency is not the U.S. dollar are translated to U.S dollars at the exchange rate prevailing on the date of transaction. Foreign currency differences on translation are recognized in other comprehensive income in the cumulative translation account net of income tax. Foreign exchange gains or losses arising from a monetary item receivable from or payable to a foreign operation, the settlement of which is neither planned nor likely to occur in the foreseeable future and which in substance is considered to form part of the net investment in the foreign operation, are recognized in other comprehensive income in the foreign currency translation reserve. c. Financial instruments Recognition Financial assets and financial liabilities are recognized in the Company’s consolidated statement of financial position when the Company becomes a party to the contractual provisions of the instrument. On initial recognition, all financial assets and financial liabilities are recorded at fair value, net of attributable transaction costs, except for financial assets and liabilities classified as at fair value through profit or loss (‘FVTPL’). The directly attributable transactions costs of financial assets and liabilities as at FVTPL are expensed in the period in which they are incurred. Subsequent measurement of financial assets and liabilities depends on the classification of such assets and liabilities. Classification and Measurement The Company determines the classification of its financial instruments at initial recognition. Financial assets and financial liabilities are classified according to the following measurement categories: ● those to be measured subsequently at fair value either through profit or loss (“FVTPL”) or through other comprehensive income (“FVTOCI”); and, ● those to be measured subsequently at amortized cost. The classification and measurement of financial assets after initial recognition at fair value depends on the business model for managing the financial asset and the contractual terms of the cash flows. Financial assets that are held within a business model whose objective is to collect the contractual cash flows, and that have contractual cash flows that are solely payments of principal and interest on the principal outstanding, are generally measured at amortized cost at each subsequent reporting period. All other financial assets are measured at their fair values at each subsequent reporting period, with any changes recorded through FVTPL or through FVTOCI (which designation is made as an irrevocable election at the time of recognition). After initial recognition at fair value, financial liabilities are classified and measured at either: ● amortized cost. ● FVTPL, if the Company has made an irrevocable election at the time of recognition, or when required (for items such as instruments held for trading or derivatives); or, ● the Company reclassifies financial assets when and only when its business model for managing those assets changes. Financial liabilities are not reclassified. The Company’s financial assets consist of cash and cash equivalents, trade and other receivables and prepaid expenses, which are classified and subsequently measured at amortized cost. The Company’s financial liabilities consist of trade and other payables, working capital facilities, promissory notes, short term loans, lease liability, relief and recovery fund payable, and other payables, which are classified and measured at amortized cost using the effective interest method. Derivative liability is classified and measured at fair value through profit and loss. Interest expense is reported in profit or loss. d. Cash equivalents Cash equivalents include short-term investments with original maturities of three months or less. e. Inventories Inventories are stated at the lower of cost and net realizable value. Cost of raw material is determined using the average cost method. Cost of semi-finished and finished goods are determined using the First in First out (FIFO) method. Cost includes all expenses directly attributable to the manufacturing process as well as appropriate portions of related production overheads. Net realizable value is the estimated selling price in the ordinary course of business less any applicable selling expenses. f. Property, plant and equipment Recognition and measurement Items of property, plant and equipment (other than land and buildings) are measured at cost less accumulated depreciation and accumulated impairment losses. Cost includes the cost of material and labor and other costs directly attributable to bringing the asset to a working condition for its intended use. When significant components of an item of property, plant and equipment have different useful lives, they are accounted for as separate items of property, plant and equipment. Gains and losses on disposal of an item of property, plant and equipment are determined by comparing the proceeds from disposal with the carrying amount of property, plant and equipment, and are recognized net within profit or loss. The Company capitalizes borrowing costs directly attributable to the acquisition, construction or production of qualifying property, plant and equipment as part of the cost of that asset, if applicable. Capitalized borrowing costs are amortized over the useful life of the related asset. The Company adopted the revaluation method of accounting for the newly acquired building and land. Land and building measured using the revaluation method is initially measured at cost and subsequently carried at its revalued amount, being the fair value at the date of the revaluation less any subsequent accumulated depreciation and any accumulated impairment losses. Revaluations are made on an annual basis to ensure that the carrying amount does not differ significantly from fair value. Where the carrying amount of an asset increases as a result of revaluation, the increase is recognized in other comprehensive income or loss and accumulated in equity in revaluation surplus, unless the increase reverses a previously recognized impairment recorded through net income, in which case that portion of the increase is recognized in net income. Where the carrying amount of an asset decreases, the decrease is recognized in other comprehensive income to the extent of any balance existing in revaluation surplus in respect of the asset, with the remainder of the decrease recognized in profit or loss. Material residual value estimates and estimates of useful life are updated as required, but at least annually. Gains or losses arising on the disposal of property, plant and equipment are determined as the difference between the disposal proceeds and the carrying amounts of the assets and are recognized in profit or loss within “other income” or “other expenses. Subsequent costs The cost of replacing a part of an item of property, plant and equipment is recognized in the carrying amount of the item if it is probable that the future economic benefits embodied within the part will flow to the Company, and its cost can be measured reliably. The carrying amount of the replaced part is derecognized. Maintenance and repair costs are expensed as incurred, except where they serve to increase productivity or to prolong the useful life of an asset, in which case they are capitalized. Depreciation is provided on a straight-line basis over the estimated useful lives of the assets. The following useful lives are applied: Schedule Of Property, Plant and Equipment Useful Lives Item Life (in years) Leasehold improvements 3 Production equipment 2 15 Office furniture and equipment 2 5 Building 20 Right of use assets Over the lease term Depreciation methods, useful lives and residual values are reviewed at each reporting date and adjusted prospectively, if appropriate. g. Leases Where the Company has entered a lease, the Company has recognized a right-of-use asset representing its rights to use the underlying assets and a lease liability representing its obligation to make lease payments. The right-of-use asset, where it relates to an operating lease, has been presented net of accumulated depreciation and is disclosed in the consolidated statement of financial position. The lease liability has been disclosed as a separate line item, allocated between current and non-current liabilities. The lease liability associated with all leases is measured at the present value of the expected lease payments at inception and discounted using the interest rate implicit in the lease. If the rate cannot be readily determined, the Company’s incremental borrowing rate is used to discount the lease liability. Judgement is required to determine the incremental borrowing rate. h. Impairment ● Financial assets The Company recognizes an allowance for credit losses equal to lifetime credit losses for trade and other receivables. None of these assets include a financing component. Significant receivable balances are assessed for impairment individually based on information specific to the customer. The remaining receivables are grouped, where possible, based on shared credit risk characteristics, and assessed for impairment collectively. The allowance assessment incorporates past experience, current and expected future conditions. ● Non-financial assets The carrying amounts of the Company’s non-financial assets, other than inventories and deferred tax assets are reviewed at each reporting date to determine whether there is any indication of impairment. If any such indication exists, then the asset’s recoverable amount is estimated. For intangible assets that are not yet available for use, the recoverable amount is estimated each year at the same time. An impairment loss is recognized if the carrying amount of an asset or its CGU exceeds its estimated recoverable amount. Impairment losses are recognized in profit or loss. Impairment losses recognized in respect of CGUs are allocated to the carrying amounts of the assets in the unit (group of units). In respect of other assets, impairment losses recognized in prior periods are assessed at each reporting date for any indications that the loss has decreased or no longer exists. An impairment loss is reversed if there has been a change in the estimates used to determine the recoverable amount. An impairment loss is reversed only to the extent that the asset’s carrying amount does not exceed the carrying amount that would have been determined, net of depreciation, if no impairment loss had been recognized. i. Provisions Legal Provisions are recognized for present legal or constructive obligations arising from past events when the amount can be reliably estimated, and it is probable that an outflow of resources will be required to settle an obligation. Provisions are measured at the estimated expenditure required to settle the present obligation, based on the most reliable evidence available at the reporting date, including the risks and uncertainties associated with the present obligation. Where there are a number of similar obligations, the likelihood that an outflow will be required in settlement is determined by considering the class of obligations as a whole. Provisions are discounted to their present values, where the time value of money is material. At the end of each reporting period, the Company evaluates the appropriateness of the remaining balances. Adjustments to the recorded amounts may be required to reflect actual experience or to reflect the current best estimate. In the normal course of operations, the Company may be subject to lawsuits, investigations and other claims, including environmental, labor, product, customer disputes and other matters. The ultimate outcome or actual cost of settlement may vary significantly from the original estimates. Material obligations that have not been recognized as provisions, as the outcome is not probable or the amount cannot be reliably estimated, are disclosed as contingent liabilities, unless the likelihood of outcome is remote. j. Share-based payments The Company accounts for all share-based payments to employees and non-employees using the fair value-based method of accounting. The Company measures the compensation cost of stock-based option awards to employees at the grant date using the Black-Scholes option pricing model to determine the fair value of the options. The share-based compensation cost of the options is recognized as stock-based compensation expense over the relevant vesting period of the stock options. Under the Company`s stock option plan, all options granted under the plan have a maximum term of 10 years and have an exercise price per share of not less than the market value of the Company’s common shares on the date of grant. The Board of Directors has the discretion to accelerate the vesting of options or stock appreciation rights granted under the plan in accordance with applicable laws and the rules and policies of any stock exchange on which the Company’s common shares are listed. The Company has an option plan whereby options are granted to employees and consultants as part of the Company’s incentive plans. Stock options vest in installments over the vesting period. Stock options typically vest one third each year over 3 years or immediately as approved by the Board. The Company treats each installment as a separate grant in determining stock-based compensation expense. The grant date fair value of options granted to employees is recognized as stock-based compensation expense, with a corresponding charge to contributed surplus, over the vesting period. The expense is adjusted to reflect the estimated number of options expected to vest at the end of the vesting period, adjusted for the estimated forfeitures during the period. Any cumulative adjustment prior to vesting is recognized in the current period. No adjustment is made to any expense recognized in the prior periods if share options ultimately exercised are different to that estimated on vesting. The fair value of options is measured using the Black-Scholes option pricing model. Measurement inputs include the price of Common shares on the measurement date, exercise price of the option, expected volatility (based on weighted average historic volatility), weighted average expected life of the option (based on historical experience and general option holder behavior), expected dividends, estimated forfeitures and the risk-free interest rate. Upon exercise of options, the proceeds received net of any directly attributable transaction costs up to the nominal value of the shares issued are allocated to share capital with any excess being recorded in retained earnings or deficit. k. Income taxes Tax expense recognized in profit or loss comprises the sum of deferred tax and current tax not recognized in other comprehensive income or directly in equity. Current income tax assets and/or liabilities comprise those obligations to, or claims from, fiscal authorities relating to the current or prior reporting periods, that are unpaid at the reporting date. Current tax is payable on taxable profit, which differs from profit or loss in the financial statements. Calculation of current tax is based on tax rates and tax laws that have been enacted or substantively enacted by the end of the reporting period. Deferred income taxes are calculated using the liability method on temporary differences between the carrying amounts of assets and liabilities and their tax bases. However, deferred tax is not provided on the initial recognition of goodwill on the initial recognition of an asset or liability unless the related transaction is a business combination or affects tax or accounting profit or transactions that at the time of the transaction, does not give rise to equal taxable and deductible temporary differences. Deferred tax on temporary differences associated with investments in subsidiaries and joint ventures is not provided if reversal of these temporary differences can be controlled by the Company and it is probable that reversal will not occur in the foreseeable future. Deferred tax assets and liabilities are calculated, without discounting, at tax rates that are expected to apply to their respective period of realization, provided they are enacted or substantively enacted by the end of the reporting period. Deferred tax assets are recognized to the extent that it is probable that they will be able to be utilized against future taxable income, based on the Company’s forecast of future operating results which is adjusted for significant non-taxable income and expenses and specific limits to the use of any unused tax loss or credit. Deferred tax assets and liabilities are offset only when the Company has a right and intention to set off current tax assets and liabilities from the same taxation authority. Changes in deferred tax assets or liabilities are recognized as a component of tax income or expense in profit or loss, except where they relate to items that are recognized in other comprehensive income or directly in equity, in which case the related deferred tax is also recognized in other comprehensive income or equity, respectively. A valuation allowance is recorded against any deferred income tax asset if it is more likely than not that the asset will be realized. l. Revenue Revenue arises from the sale of goods and the rendering of services. It is measured by reference to the fair value of consideration received or receivable, excluding sales taxes, rebates, and trade discounts. The Company often enters sales transactions involving a range of the Company’s products and services, for example for the delivery of battery systems and related services. Sale of goods Sale of goods and services is recognized when the Company has transferred to the buyer the significant risks and rewards of ownership, generally when the customer has taken undisputed delivery of the goods and services. For contracts that permit the customer to return an item, revenue is recognized to the extent that it is highly probable that a significant reversal in the amount of cumulative revenue recognized will not occur. Therefore, the amount of revenue recognized is adjusted for expected returns, which are estimated based on the historical data for specific types of products. Advance payments by customers - Any advance receipts from customers are included in contract liabilities until the revenue recognition criteria is met. Warranty provision A provision for warranty costs is recorded on product sales at the time the sale is recognized. In establishing the warranty provision, management estimates the likelihood that products sold will experience warranty claims and the estimated cost to resolve claims received, taking into account the nature of the contract and past and projected experience with the products. Government Grants Government grants are recognized when there is reasonable assurance that the Company has met the requirements of the approved grant program and there is reasonable assurance that the grant will be received. Government grants that compensate for expenses already incurred are recognized in income on a systematic basis in the same year in which the expenses are incurred. Government grants for immediate financial support, with no future related costs, are recognized in income when receivable. Government grants that compensate the Company for the cost of an asset are recognized on a systematic basis over the useful life of the asset. Government grants consisting of investment tax credits are recorded as a reduction of the related expense or cost of the asset acquired. If a government grant becomes repayable, the repayment is treated as a change in estimate. Where the original grant related to income, the repayment is applied first against any related deferred government grant balance, and any excess as an expense. Where the original grant related to an asset, the repayment is treated as an increase to the carrying amount of the asset or as a reduction to the deferred government grant balance. m. Research and development Expenditure on research is recognized as an expense in the period in which it is incurred. Costs that are directly attributable to the development phase are recognized as intangible assets provided, they meet the following recognition requirements: ● completion of the intangible asset is technically feasible so that it will be available for use or sale. ● the Company intends to complete the intangible asset and use or sell it. ● the Company has the ability to use or sell the intangible asset. ● the intangible asset will generate probable future economic benefits. Among other things, this requires that there is a market for the output from the intangible asset or for the intangible asset itself, or, if it is to be used internally, the asset will be used in generating such benefits. ● there are adequate technical, financial and other resources to complete the development and to use or sell the intangible asset. ● the expenditure attributable to the intangible asset during its development can be measured reliably. Development costs not meeting these criteria for capitalization are expensed in profit or loss as incurred. n. Finance income and expense, foreign currency gains and losses Interest income is reported on an accrual basis using the effective interest method. Finance costs are comprised of interest expense on promissory notes, short term loans and working capital facilities. Borrowing costs that are not directly attributable to the acquisition, construction or production of a qualifying asset are recognized in profit or loss using the effective interest method. Foreign currency gains and losses are reported on a net basis. o. Earnings per share (EPS) The Company presents basic and diluted earnings per share (“EPS”) data for its common shares. Basic EPS is calculated by dividing the profit or loss attributable to common shareholders of the Company by the weighted average number of common shares outstanding during the period. Diluted EPS is determined by adjusting the profit or loss attributable to common shareholders and the weighted average number of common shares outstanding, adjusted for own shares held, for the effects of all dilutive potential common shares, which comprise share options granted to employees. In a period of losses, the dilutive instruments comprising warrants and stock options are excluded for the determination of dilutive net loss per share because their effect is anti-dilutive. p. Segment reporting An operating segment is a component of the Company that engages in business activities from which it may earn revenues and incur expenses, including revenues and expenses that relate to transactions with any of the Company’s other components. All operating segments’ operating results are regularly reviewed by the Company’s chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and for which discrete financial information is available.

Standards issued but not yet ef

Standards issued but not yet effective	12 Months Ended
	Sep. 30, 2024
Standards Issued But Not Yet Effective
Standards issued but not yet effective	4. Standards issued but not yet effective The IASB and the IFRIC have issued the following new and revised standards and interpretations that are not yet effective for the relevant reporting periods and the Company has not early adopted these standards, amendments and interpretations. However, the Company is currently assessing what impact the application of these standards or amendments will have on the Consolidated Financial Statements of the Company. The Company intends to adopt these standards, if applicable, when the standards become effective: a. Lease Liability in a Sale and Leaseback (Amendments to IFRS 16) The amendments address the measurement requirements for sale and leaseback transactions. The amendments require a seller-lessee to subsequently measure lease liabilities arising from a leaseback in a way that it does not recognize any amount of the gain or loss that relates to the right of use it retains. The amendments are effective for annual reporting periods beginning on or after January 1, 2024. Earlier application is permitted. A seller-lessee shall apply the amendments retrospectively to sale and leaseback transactions entered into after the date of initial application. The date of initial application is the beginning of the annual reporting period in which an entity first applies IFRS 16. b. Classification of Liabilities as Current or Non-Current and Non-Current Liabilities with Covenants (Amendments to IAS 1) ● Liabilities are classified as either current or non-current depending on the existence at the end of the reporting period of a right to defer settlement of the liability for at least twelve months after the reporting period. The amendments also clarify that only covenants that an entity must comply with on or before the reporting date would affect a liability’s classification as current or non-current, even if compliance with the covenant is only assessed after the entity’s reporting date. Classification is unaffected by the likelihood that an entity will settle the liability within 12 months after the reporting date; and ● How an entity classifies debt an entity may settle by converting it into equity. Additionally, the amendments added new disclosure requirements for situations where a liability is classified as non-current and the entity’s right to defer settlement is contingent on compliance with future covenants within twelve months after the reporting date. The disclosure should enable users of financial statements to understand the risk that the liability classified as non-current could become repayable within 12 months after the reporting period. Amendments are effective for annual reporting periods beginning on or after January 1, 2024, and do not have any impact on the Company’s reporting requirements. c. Lack of Exchangeability (Amendments to IAS 21) The amendments specify how to determine whether a currency is exchangeable into another currency and how to determine the spot exchange rate when a currency lacks exchangeability. The amendments are effective for annual reporting periods beginning on or after January 1, 2025. In applying the amendments, an entity shall not restate comparative periods but will follow the specific transitional provisions included in the amendments. d. IFRS 18 Presentation and Disclosure in Financial Statements (New) IFRS 18 replaces IAS 1 Presentation of Financial Statements, and for all entities will- ● Introduce a new defined structure for the statement of profit and loss and require the classification of income and expenses in that statement into one of five categories: operating; investing; financing; income taxes; and discontinued operations. IFRS 18 introduces definitions of these categories for purposes of the statement of profit and loss. Specific categorization requirements will apply to entities whose ‘main business activity’ is to provide financing to customers or to invest in specified assets. Entities will also be required to present new subtotals for ‘operating profit or loss’ and ‘profit or loss before financing and income taxes. ● Require disclosure of ‘management-defined performance measures’ (MPMs) in a single note to the financial statements. MPMs are subtotals of income and expenses that an entity uses in public communications outside of its financial statements, to communicate management’s view of an aspect of the financial performance of the entity as a whole to users. Entities must disclose a reconciliation between the measure and the most directly comparable total or subtotal specifically required to be disclosed by IFRS Accounting Standards or subtotal listed in IFRS 18. ● Enhance guidance about how to group information within the financial statements; and ● For the statement of cash flows, require that ‘operating profit or loss’ be used as the starting point for determining cash flows from operating activities under the indirect method, and remove the optionality around classification of cash flows from interest and dividends. IFRS 18 is effective for annual reporting periods beginning on or after January 1, 2027, including for interim financial statements. Earlier application is permitted. The new standard is to be applied retrospectively, and, in the year of adoption, a reconciliation is required between how the statement of profit or loss was presented in the comparative period under IAS 1 and how it is presented in the current year under IFRS 18.

Trade and Other Receivables

Trade and Other Receivables	12 Months Ended
	Sep. 30, 2024
Trade And Other Receivables
Trade and Other Receivables	5. Trade and Other Receivables Trade and Other Receivables September 30, 2024 September 30, 2023 Trade receivables, gross 10,577 9,404 Expected credit losses (64 ) (257 ) Trade receivables 10,513 9,147 Other receivables 779 1,464 Trade and other receivables 11,292 10,611 As at September 30, 2024, 0.77 7.18 Accounts receivable Particulars Current 31-60 61-90 91-120 >120 Total % 78.52 20.61 0.10 0.02 0.75 100 Gross Trade receivable 8,305 2,180 11 4 77 10,577 Particulars Current 31-60 61-90 91-180 181-365 >365 Total Trade receivable (net of specific provision) 8,305 2,180 11 4 29 48 10,577 Expected loss rate (%) 0.05 0.24 0.42 1.06 19.62 100 0.61 Expected loss provision 4 6 — — 6 48 64 The movement in the allowance for credit losses can be reconciled as follows: Allowance for Credit Losses September 30, 2024 September 30, 2023 Beginning balance 257 54 Write off (244 ) — Allowance provided 51 203 Ending balance 64 257

Inventories

Inventories	12 Months Ended
	Sep. 30, 2024
Schedule Of Inventories
Inventories	6. Inventories a. Total inventories on hand as at September 30, 2024 and September 30, 2023 are as follows: Schedule of Inventories September 30, 2024 September 30, 2023 Raw materials 8,433 6,553 Semi-finished 324 165 Finished goods 941 1,548 9,698 8,266 b. During the year ended September 30, 2024, the provision for slow moving and obsolete inventories amounted to $ 225 162 c. During the year ended September 30, 2024, materials amounted to $ 29.25 30.69

Revaluation of land and buildin

Revaluation of land and building	12 Months Ended
	Sep. 30, 2024
Revaluation Of Land And Building
Revaluation of land and building	7. Revaluation of land and building The Company has revalued its land and building as at March 31, 2023, and recognized a revaluation surplus of $ 2,600 679 Schedule of Revaluation of Land And Building High Low Market rent ($ sq ft) $ 7.10 $ 3.14 Capitalisation rate 13.70 % 9.50 % Sales ($ sq ft) $ 56.87 $ 35.41 The Company’s estimates are, by their nature, subject to change. Changes in the capitalization rate would represent a change in the value of the land and buildings. The Company performed a sensitivity analysis on the value of the land and buildings based on changes to the capitalisation rate. As at March 31, 2023, 1 800

Prepaid expenses

Prepaid expenses	12 Months Ended
	Sep. 30, 2024
Prepaid Expenses
Prepaid expenses	8. Prepaid expenses Schedule of Prepaid Expenses September 30, 2024 September 30, 2023 Prepaid expenses 612 486 Prepaid insurance 54 108 Prepaid purchases 6,981 5,403 Total 7,647 5,997 Prepaid purchases are comprised of vendor deposits on inventory orders for the future acquisition of inventories.

Property, plant and equipment

Property, plant and equipment	12 Months Ended
	Sep. 30, 2024
Property Plant And Equipment
Property, plant and equipment	9. Property, plant and equipment Schedule Of Property, Plant and Equipment September 30, 2024 Land & Building Right of Use Leasehold Production Office Furniture & Equipment Total Gross carrying amount Balance beginning 7,700 3,197 76 1,712 73 12,758 Additions — — — 94 31 125 Exchange differences — 6 — 3 1 10 Balance ending 7,700 3,203 76 1,809 105 12,893 Depreciation and impairment Balance beginning (419 ) (1,127 ) (33 ) (970 ) (60 ) (2,609 ) Additions (374 ) (454 ) (15 ) (221 ) (11 ) (1,075 ) Exchange differences — (3 ) — (3 ) (1 ) (7 ) Balance ending (793 ) (1,584 ) (48 ) (1,194 ) (72 ) (3,691 ) Net Book Value ending 6,907 1,619 28 615 33 9,202 September 30, 2023 Land & Building Right of Use Leasehold Production Office Furniture & Equipment Total Gross carrying amount Balance beginning 5,105 2,582 39 1,240 56 9,022 Additions 2,595 573 37 452 16 3,673 Exchange differences — 42 — 20 1 63 Balance ending 7,700 3,197 76 1,712 73 12,758 Depreciation and impairment Balance beginning (104 ) (710 ) (20 ) (819 ) (55 ) (1,708 ) Additions (315 ) (406 ) (12 ) (138 ) (4 ) (875 ) Exchange differences — (11 ) (1 ) (13 ) (1 ) (26 ) Balance ending (419 ) (1,127 ) (33 ) (970 ) (60 ) (2,609 ) Net Book Value ending 7,281 2,070 43 742 13 10,149 For the year ended September 30, 2023, the additions include revaluation adjustment of $ 2.6

Trade and Other Payables

Trade and Other Payables	12 Months Ended
	Sep. 30, 2024
Trade And Other Payables
Trade and Other Payables	10. Trade and Other Payables Schedule of Trade and Other Payables September 30, 2024 September 30, 2023 Trade payables 7,073 6,037 Accruals 1,732 1,197 Employee payables 655 1,186 Total 9,460 8,420 Warranty provision is included in accruals and the continuity schedule is as follows: Schedule of Warranty Provisions September 30, 2024 September 30, 2023 Opening provision 250 — Warranty expenses during the year (672 ) (728 ) Additional provision during the year 1,494 978 Closing balance 1,072 250

Working Capital Facilities

Working Capital Facilities	12 Months Ended
	Sep. 30, 2024
Working Capital Facilities
Working Capital Facilities	11. Working Capital Facilities a. Revolving Credit Facility As at September 30, 2024 the balance owing under the facility is $16.28 million (Cdn $22 million). The maximum credit available under the facility is $ 16.28 The interest on the revolving credit facility is the greater of a) 7.05% per annum above the Prime Rate or b) 12% per annum. Interest is payable monthly. Schedule Of Revolving Credit Facility September 30, 2024 September 30, 2023 Opening balance 11,821 11,635 Exchange difference 20 186 Payments made during the period (47,805 ) (34,184 ) Cash drawn during the period 52,247 34,184 Closing balance 16,283 11,821 On December 20, 2022, the Company renewed its revolving facility and extended the term of the facility by six months to June 30, 2023, with the Company having the option to extend the facility by a further six months to December 31, 2023. In exchange for this renewal and amendment to the definition of “Credit Facility Advance Rate Limit”, the Company issued 14,414 On June 30, 2023, the Company renewed its revolving facility and extended the term of the facility by three months to September 29, 2023, with the Company having the option to extend the facility by a further three months to December 31, 2023. In exchange for this renewal, the Company issued 8,376 On September 29, 2023, the Company renewed its revolving facility and extended the term of the facility by three months to December 29, 2023. In exchange for this renewal, the Company issued 10,443 On February 12, 2024, the Company revised its revolving facility, expanding its maximum principal amount to $22 million and extending its term to July 29, 2025. As part of this adjustment, a commitment fee of $ 303 b. Promissory Note Schedule Of finance cost and credited September 30, 2024 September 30, 2023 Promissory Note opening balance 1,026 4,363 Finance cost 37 126 Repayment of Promissory Note — (4,489 ) Repayment of Promissory Note (i) (507 ) — Finance cost paid with options (i) (37 ) — Promissory Note (ii) — 1,050 Repayment of Promissory Note (i) — (24 ) Promissory Note Ending balance $ 519 $ 1,026 i. On November 14, 2022, the Company repaid the promissory note in the amount of approximately $4.4 million (Cdn $6 million) via the proceeds of an equity raise. Upon repayment, the pledge of 27,500,000 Common Shares by Dr. Das Gupta on the share certificates was cancelled. On February 16, 2024, the Executive Chairman and Chief Executive Officer both exercised options of Electrovaya Inc. A sum of $507 from the promissory note was utilized to cover portion of the options’ purchase price. The remaining balance of the promissory note, amounting to $519, was then substituted with a new promissory note on February 28, 2024, carrying a 14% interest rate and maturing on July 31, 2025. The interest accrued on the new promissory note is US $ 0.43 million ii. On March 31, 2023, the Company purchased 100% of the membership interest in Sustainable Energy Jamestown LLC (‘SEJ”), a New York incorporated company controlled by the majority shareholders of the Company. In return, the Company issued a promissory note for $1.05 million to the members of SEJ, with a term of 365 days bearing interest at 7.5% annually payable at maturity. Interest recorded for the year is $0.76 million (September 30, 2023: $0.39 million).

Short term loans

Short term loans	12 Months Ended
	Sep. 30, 2024
Short Term Loans
Short term loans	12. Short term loans The short-term loan, having a principal amount of $ 364 1.8 The short-term loans, having principal amount of $ 218 The loans had interest at 2% per month and carried a commitment fee of 5 On May 16, 2022, the Company acquired the assets and liabilities of Sustainable Energy Jamestown (“SEJ”), including a Vendor Take Back (‘VTB”) note relating to the purchase of the property by SEJ. The secured VTB has a two-year term with repayment starting on July 1, 2022, and expiring on December 18, 2024, and carries interest at 2% per annum. The VTB note is secured against the real estate property that was acquired as part of the SEJ transaction. On October 1, 2024, the VTB was further extended to December 18, 2024. The VTB carries a balloon payment of $ 1.63 3.45 Schedule Of Short term loans September 30, 2024 September 30, 2023 Vendor take back 1630 3,457 Schedule Of Short term VTB continuity The VTB continuity is as follows: Opening balance as at May 22, 2022 (Short term: $419. Long term: $3,826) 4,245 Repaid in year (150 ) Interest accretion 35 Closing balance as at September 30, 2022 (Short term: $673. Long term: $3,457) 4,130 Repaid in year (750 ) Interest accretion 77 Closing balance as at September 30, 2023 (Short term: $3,457. Long term: $nil) 3,457 Repaid in year (1,879 ) Interest accretion 52 Closing balance as at September 30, 2024 (Short term: $1,630 Long term : $nil) 1,630

Finance costs

Finance costs	12 Months Ended
	Sep. 30, 2024
Finance Costs
Finance costs	13. Finance costs During the year, the Company incurred both cash and non-cash finance costs. The following table shows the split as included on the statement of earnings. Schedule Of cash and non-cash finance costs September 30, 2024 September 30, 2023 Cash Non-Cash Total Cash Non-Cash Total Working capital facility 2,134 — 2,134 1,543 — 1,543 Issued to lender (note 15a) — 30 30 — 118 118 Shares issued to consultants — 169 169 — — — Promissory notes, accretion on promissory note and settlement fee on promissory note — 76 75 173 32 205 Interest on VTB loan (note 12) 96 52 148 77 — 77 Lease interest (note 14) — 349 348 — 380 380 Equity issuance costs 301 — 301 84 — 84 Warrant issuance costs — — — 134 — 134 Changes in FV of derivative warrants — (1,334 ) (1,334 ) — (361 ) (361 ) Accretion on government assistance — 48 48 — — — Accretion on government loans – TPC 2 443 446 — 294 294 2,533 (167 ) 2,366 2,011 463 2,474

Lease liability

Lease liability	12 Months Ended
	Sep. 30, 2024
Lease Liability
Lease liability	14. Lease liability As of September 30, 2024, lease liability consists of: Schedule Of Lease liability September 30, 2024 September 30, 2023 Current 471 389 Non-current 1,871 2,338 Carrying amount - lease liability 2,342 2,727 Information about leases for which the Company is a lessee is as follows: Schedule Of Lease September 30, 2024 September 30, 2023 Interest on lease liabilities 349 380 Incremental borrowing rate at time of transition 14 % 14 % Cash outflow for the lease 735 707 The Company’s future minimum lease payments for the years ended September 30, 2024, for the continued operations are as under: Schedule Of minimum lease payments Year Amount 2025 760 2026 598 2027 555 2028 571 2029 588 2030 and beyond 148 The Company entered into a lease agreement for 61,327 sq. ft for its premises as its headquarters in Mississauga, Ontario at 6688 Kitimat Road. The lease is for 10 years starting January 1, 2020, with expiry December 31, 2029. In addition, the Company is required to pay certain occupancy costs. The lease agreement for the Company’s lab facility has been renewed for an additional three years, commencing from January 2023. The terms of the renewed lease entail a fixed monthly rent as follows: ● CAD $ 25,625 ● CAD $ 26,265 ● CAD $ 26,922

Share capital

Share capital	12 Months Ended
	Sep. 30, 2024
Share Capital
Share capital	15. Share capital a. Authorized and issued capital stock Schedule Of Authorized and issued capital stock Common Shares Number Amount Balance, September 30, 2022 Note 29,437,372 $ 103,305 Issuance of shares (i) 3,508,680 7,167 Exercise of options Note 15(b) 6,800 8 Issuance of shares (ii) 14,414 59 Transfer from contributed surplus — 5 Exercise of options Note 15(b) 5,200 13 Transfer from contributed surplus — 11 Issuance of shares note (iii) 8,376 30 Issuance of shares note (iv) 10,443 30 Exercise of warrants Note 15(c) 841,499 3,004 Transfer from derivative liability — 1,409 Balance, September 30, 2023 33,832,784 115,041 Issuance of shares (v) 10,024 30 Issuance of shares (vi) 42,157 169 Transfer from contributed surplus — 501 Exercise of options Note 15(b) 252,700 667 Balance, September 30, 2024 34,137,665 116,408 i. The Company completed a non-brokered private placement of 3,508,680 4.23 1,754,340 The warrant exercise price would be adjusted from $5.30 to $4.70 ii. On December 20, 2022, the revolving facility note which was due to mature on December 31, 2022, was amended to June 30, 2023, with an option to renew for further six months until December 31, 2023. The terms include a reduction in the interest rate calculation by 1%. All other terms and conditions were unchanged. In exchange for the extension, the Company issued 14,414 5.55 iii. The revolving facility, which was due to mature on June 30, 2023, was amended to September 29, 2023 with an option to renew for further three months until December 31, 2023. All other terms and conditions were unchanged. In exchange for the extension, the Company issued 8,376 40 iv. The revolving facility, which was due to mature on September 29, 2023, was amended to December 29, 2023. All other terms and conditions are unchanged. In exchange for the extension, the Company issued 10,443 3.83 40 v. In December 2023, additional shares were issued as extension fee for the revolving facility on December 20, 2023. All terms and conditions were unchanged. In exchange for the extension, the Company issued 10,024 3.99 40 vi. On March 07, 2024, the Company issued 42,157 shares for consulting for investor relations. The Company issued the shares at Cdn $ 5.43 as compensation. vii. On June 13, 2023, the Company completed a reverse split of its issued and outstanding common stock at a ratio of 1 consolidated for 5 pre-consolidated shares. The Company initiated the reverse stock split in connection with its intention to meet the minimum bid price requirement and list the Common Shares for trading on the Nasdaq Capital Market. As a result of the reverse stock split, every five outstanding Common Shares were consolidated into one Common Share without any action from stockholders, reducing the number of outstanding Common Shares from approximately 164.86 million to approximately 32.97 million b. Stock Options Options to purchase common shares of the Company under its stock option plan may be granted by the Board of Directors of the Company to certain full-time and part-time employees, directors and consultants of the Company and its affiliates. Stock options are non-assignable and may be granted for terms of up to 10 years. Stock options vest at various periods from zero to three years. As a result of the reverse stock split, every five options were consolidated into one option without any action from option holders, reducing the number of outstanding options from approximately 23.5 million to 4.7 million On February 17, 2021, at a Special Meeting of the Shareholders, a resolution was passed to (i) authorize amendments to the Company’s Stock Option Plan to increase the maximum number of common shares issuable upon the exercise of stock options thereunder from 3,020,000 to 4,600,000 On March 25, 2022, at a Special Meeting of the Shareholders, a resolution was passed to (i) authorize amendments to the Company’s Stock Option Plan to increase the maximum number of common shares issuable upon the exercise of stock options thereunder from 4,600,000 to 6,000,000 Schedule Of Stock Options Note Number outstanding Weighted average exercise price Outstanding, September 30, 2022 3,727,588 2.30 Exercised Note 15(a) (6,800 ) 1.05 Exercised Note 15(a) (5,200 ) 2.55 Expired Note 15(a) (3,200 ) 2.60 Granted 1,060,000 4.04 Cancelled (58,000 ) 4.04 Outstanding, September 30, 2023 4,714,388 2.44 Exercised during the year Note 15(a) (252,700 ) 2.65 Expired during the year Note 15(a) (24,400 ) 2.87 Granted 443,000 3.42 Outstanding, September 30, 2024 4,880,288 2.52 Exercise price Number Outstanding Weighted average remaining life (years) Number exercisable Weighted average exercise price $ 3.46 (Cdn 4.68) 443,000 9.51 87,000 3.46 $ 3.96 (Cdn 5.35) 1,002,000 8.53 161,338 3.96 $ 2.11 (Cdn 2.85) 298,000 7.72 234,675 2.11 $ 4.26 (Cdn 5.75) 20,000 7.16 20,000 4.26 $ 3.70 (Cdn 5) 1,494,667 6.95 694,667 3.70 $ 2.44 (Cdn 3.3) 270,268 5.95 270,268 2.44 $ 1.11 (Cdn 1.5) 1,024,000 4.83 1,024,000 1.11 $ 1.04 (Cdn 1.4) 116,566 3.39 116,566 1.04 $ 4.51 (Cdn 6.1) 10,667 2.83 10,667 4.51 $ 7.88 (Cdn 10.65) 101,121 2.25 101,121 7.88 $ 2.92 (Cdn 3.95) 9,600 1.36 9,600 2.92 $ 2.55 (Cdn 3.45) 42,900 1.00 42,900 2.55 $ 3.37 (Cdn 4.55) 12,000 0.64 12,000 3.37 $ 2.41 (Cdn 3.25) 35,499 0.39 35,499 2.41 4,880,288 2,820,301 2.52 For the options exercised, the share price at the time of exercise was between CDN $2.47-$4.06. Total stock-based compensation expense recognized during the year ended September 30, 2024 was $2,155 (2023: $1,167) The Company amortize the estimated grant date fair value of stock options to expense over the vesting period (generally three years). The grant date fair value of outstanding stock options was determined using the Black-Scholes option pricing model which uses highly subjective and complex assumptions, including the option’s expected term and the price volatility of the underlying stock based on historical stock prices, to determine the fair value of the option. i. The following table summarizes the assumptions used with the Black-Scholes valuation model for the determination of the stock-based compensation costs for the stock options granted during the year ended September 30, 2024 Schedule Of stock-based compensation costs Grant date April 05, 2024 No of options 443,000 Share price $ 3.44 Exercise price $ 3.44 Average expected life in years 10 Volatility 87.98 % Risk-free weighted interest rate 3.58 % Dividend yield — Fair-value of options granted $ 1,316 ii. The following table summarizes the assumptions used with the Black-Scholes valuation model for the determination of the stock-based compensation costs for the stock options granted during the year ended September 30, 2023: Grant date April 10, 2023 No of options 1,060,000 Share price $ 3.85 Exercise price $ 4.04 Average expected life in years 10 Volatility 79.30 % Risk-free weighted interest rate 2.92 % Dividend yield — Fair-value of options granted $ 4,282 c. Warrants Details of Share Warrants Schedule Of Warrants Number Outstanding Exercise Price Outstanding, September 30, 2023 1,711,924 $ 2.38 Expired (291,924 ) $ 5.92 Outstanding, September 30, 2024 1,420,000 $ 2.38 Additionally, the number of derivative warrants at September 30, 2024 were 912,841 The grant date fair value of outstanding share warrants was determined using the Black-Scholes pricing model using the following assumptions in the year of the grant: Risk-free interest rate (based on U.S. government bond yields) of 2.94 52.72 reducing the number of outstanding warrants from approximately 13.1 million to 2.6 million. A 10% of change in any assumption would result in the change in derivative warrant liability between $(51) (September 30, 2023: ($417)) and $(2) (September 30, 2023: $393) Warrant continuity schedule is as follows: Schedule Of Warrant continuity Units Fair Value Opening valuation as at Nov 9, 2022 1,754,340 3,259 Warrants exercised as at July 28, 2023 (841,499 ) (1,409 ) Fair value adjustment (361 ) Closing balance (September 30, 2023) 912,841 1,489 Fair value adjustment — (1,334 ) Closing balance (September 30, 2024) 912,841 155 d. Details of Compensation options: Schedule Of Details of Compensation options Number Outstanding Exercise Price Outstanding, September 30, 2023 17,522 4.95 Expired during the year (17,522 ) 6.70 Outstanding, September 30, 2024 — —

Related Party Transactions

Related Party Transactions	12 Months Ended
	Sep. 30, 2024
Related Party Transactions
Related Party Transactions	16. Related Party Transactions Management compensation Key management compensation comprises the following: Schedule of related party transactions Management compensation September 30, 2024 September 30, 2023 Salaries, bonus and other benefits 1,185 764 Share based compensation 969 1,089 Key Management Personnel Compensation 2,154 1,853 Share based compensation includes a portion of options that are granted but have not vested and are valued using the Monte Carlo valuation method. See details in Special Option Grants below: Personal Guarantees Schedule of accrued interest September 30, 2024 September 30, 2023 Promissory Note (note 11(b)) 519 1,026 Research Lab – Facility Usage Agreement In May 2021, Electrovaya entered a month-to-month Facility Usage Agreement for the use of space and allocated staff of a third-party research firm providing access to laboratory facilities, primarily for research. The laboratory and pilot plant facilities have certain equipment and permits for research and developments with chemicals. The term of the agreement was for six months and could be terminated by either party upon 90 days notice. In July 2021, the facility was acquired by an investor group controlled by the family of Dr. Sankar Das Gupta, which includes its CEO, Dr. Rajshekar Das Gupta. The Facility Usage Agreement was not changed on the change of ownership and remains in effect between the Company and the owner, such that the monthly payment of Cdn $25,265 is now made to a related party of Electrovaya. On June 7, 2023, the Facility Usage Agreement was retroactively extended from January 1, 2023, for an additional three years. The lease has been recognized as a lease liability and corresponding right of use asset. Special Options Grants In September 2021, on the recommendation of the Compensation Committee of the Company, a committee composed entirely of independent directors, the Board of Directors of the Company determined that it is advisable and in the best interests of the Company to amend the terms of the compensation of certain key personnel to incentivize future performance, to encourage retention of their services, and to align their interests with those of the Company’s shareholders. Dr. Sankar Das Gupta was granted 700,000 200,000 300,000 456 256 Dr. Rajshekar Das Gupta was granted 900,000 300,000 248 In April 2023, following the suggestion of the Company’s Compensation Committee, consisting entirely of independent directors, the Company’s Board of Directors awarded Dr. Rajshekar Das Gupta a total of 600,000 options. These options will vest in two phases: 300,000 options and 300,000 options, contingent upon achieving certain target market capitalizations. The expense of $ 512 260 Investment in Sustainable Energy Jamestown LLC During the year ended September 30, 2022, the Company acquired real estate (land and building) through its common control entity Sustainable Energy Jamestown (“SEJ”), a limited liability company controlled by the major shareholders of the Company. SEJ purchased the land and buildings for $ 5.1 600 4.4 105 During the year ended September 30, 2023, the Company purchased the membership interest in SEJ from the major shareholders of the Company. The land and buildings comprising the real estate was revalued by $ 2.7 500

Change in Non-Cash Operating Wo

Change in Non-Cash Operating Working Capital	12 Months Ended
	Sep. 30, 2024
Change In Non-cash Operating Working Capital
Change in Non-Cash Operating Working Capital	17. Change in Non-Cash Operating Working Capital Schedule Of Change in Non-Cash Operating Working Capital September 30, 2024 September 30, 2023 Trade and other receivables (732 ) (7,845 ) Inventories (1,418 ) (724 ) Prepaid expenses and other (1,693 ) (2,103 ) Trade and other payables 1,588 2,551 Total (2,255 ) (8,121 )

Relief and Recovery Fund Payabl

Relief and Recovery Fund Payable	12 Months Ended
	Sep. 30, 2024
Relief And Recovery Fund Payable
Relief and Recovery Fund Payable	18. Relief and Recovery Fund Payable The Relief and recovery fund is created by the Ministry of Economic Development to support the Company to recover from economic disruption associated with the COVID-19 outbreak. An amount of $ 300 5

Government Assistance

Government Assistance	12 Months Ended
	Sep. 30, 2024
Government Assistance
Government Assistance	19. Government Assistance The government assistance is related to specific Government supported research and development programs undertaken by Electrovaya. The National Research Council of Canada Industrial Research Assistance Program (IRAP) has provided $ 133 36

Financial Instruments

Financial Instruments	12 Months Ended
	Sep. 30, 2024
Financial Instruments
Financial Instruments	20. Financial Instruments Derivative Liabilities Warrants as derivative liability is fair valued using Black Scholes Model (“BSM”). Using this approach, the fair value of the warrants on November 09, 2022, was determined to be $ 3.3 3 85.58 3.87 0.0 Key valuation inputs and assumptions used in the BSM when valuing the warrants as at September 30, 2024, were, stock price $3.16, expected life of 1.1 52.72 2.94 0.0 The Company incurred total issuance costs of $ 459 134 325 Fair Value IFRS 13 “Fair Value Measurement” provides guidance about fair value measurements. Fair value is defined as the exchange price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value are required to maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy is based on three levels of inputs. The first two levels are considered observable and the last unobservable. These levels are used to measure fair values as follows: ● Level 1 – Quoted prices (unadjusted) in active markets for identical assets or liabilities, either directly or indirectly. ● Level 2 – Inputs, other than Level 1 inputs that are observable for assets and liabilities, either directly or indirectly. Level 2 inputs include quoted market prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. ● Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Schedule Of Warrant Fair Value Fair Value Level 1 Level 2 Level 3 Warrants 155 — 155 — Risk Management The Company may be exposed to risks of varying degrees of significance which could affect its ability to achieve its strategic objectives. The main objectives of the Company’s risk management processes are to ensure that the risks are properly identified and that the capital base is adequate in relation to those risks. The principal risks to which the Company is exposed are described below. There have been no changes in risk exposure since the prior year unless otherwise noted. Capital risk The Company manages its capital to ensure that there are adequate capital resources for the Company to maintain and develop its products. The capital structure of the Company consists of shareholders’ equity and depends on the underlying profitability of the Company’s operations. The Company manages its capital structure and makes adjustments to it, based on the funds available to the Company, in order to support the development, manufacture and marketing of its products. The Board of Directors does not establish quantitative return on capital criteria for management, but rather relies on the expertise of the Company’s management to sustain future development of the business. The Company’s capital management objectives are: ● to ensure the Company’s ability to continue as a going concern. ● to provide an adequate return to shareholders by pricing products and services commensurately with the level of risk. The Company monitors capital based on the carrying amount of equity plus its short-term debt comprised of the promissory notes, less cash and cash equivalents as presented on the face of the consolidated statement of financial position. The Company sets the amount of capital in proportion to its overall financing structure, comprised of equity and long-term debt. The Company manages the capital structure and makes adjustments to it in the light of changes in economic conditions and the risk characteristics of the underlying assets. In order to maintain or adjust the capital structure, the Company issues new shares or increases its long-term debt. Credit risk and Concentration risk Credit risk is the risk that the counterparty fails to discharge an obligation to the Company. The Company is exposed to this risk due to its cash and cash equivalents, trade and other receivables. The Company manages its credit risk related to trade and other receivables by establishing procedures to establish credit limits and approval policies. The balance in trade and other receivables is primarily attributable to trade accounts receivables. In the opinion of management, the credit risk is moderate and minimum credit losses are expected. Management is taking appropriate action to mitigate this risk by adjusting credit terms. The Company is exposed to credit risk in the event of default by its customers. Accounts receivables are recorded at the invoiced amount, do not bear interest, and do not require collateral. For the year ended September 30, 2024, two customers accounted for $38.9 million or 87.21% of revenue (2023 one customer accounted for $42 million or 94%). As of September 30, 2024, two customers accounted for 96 % of accounts receivable (2023 one customer accounted for 85%). Liquidity risk Liquidity risk is the risk that the Company may not have cash available to satisfy its financial obligations as they come due. The majority of the Company’s financial liabilities recorded in accounts payable, accrued and other current liabilities and provisions are due within 90 days. The Company manages liquidity risk by maintaining a portfolio of liquid funds and having access to a revolving credit facility. The Company believes that cash flow from operating activities, together with cash on hand, cash from its trade and other receivables, and borrowings available under the revolving facility are sufficient to fund its currently anticipated financial obligations and will remain available in the current environment. The following are the undiscounted contractual maturities of significant financial liabilities and the total contractual obligations of the Company as at September 30, 2024: Schedule Of financial liabilities 2025 2026 2027 2028 2029 & beyond Total Trade and other payables 9,460 — — — — 9,460 Lease liability 760 598 555 571 588 3,072 Short term loan 1,630 — — — — 1,630 Promissory notes 519 — — — — 519 Working capital facility 16,283 — — — — 16,283 Other payable 211 188 208 218 610 1,435 Total financial liabilities 28,863 786 763 789 1,198 32,399 The following are the undiscounted contractual maturities of significant financial liabilities and the total contractual obligations of the Company as at September 30, 2023: 2024 2025 2026 2027 2028 & beyond Total Trade and other payables 8,429 — — — — 8,429 Lease liability 929 950 789 745 1,737 5,150 Short term loans 3,500 — — — — 3,500 Promissory note 1,026 — — — — 1,026 Working capital facility 11,821 — — — — 11,821 Other payable 1,365 490 215 56 38 2,164 Total financial liabilities 27,070 1,440 1,004 801 1,775 32,090 Market risk Market risk incorporates a range of risks. Movement in risk factors, such as market price risk and currency risk, affect the fair value of financial assets and liabilities. The Company is exposed to these risks as the ability of the Company to develop or market its products and the future profitability of the Company is related to the market price of its primary competitors for similar products. Interest rate risk The Company has variable interest debt as described in Note 11 and 13. Changes in interest rates will affect future interest expense and cash flows. The Company does not enter into derivative instruments to reduce this exposure. Foreign currency risk The Company is exposed to foreign currency risk. The Company’s functional currency is the United States dollar (Electrovaya Inc.’s functional currency is CAD) and the financial statements are presented in United States dollars. Changes in the relative values of these currencies will give rise to changes in other comprehensive income. Purchases are transacted in Canadian dollars, United States dollars and Euro. Management believes the foreign exchange risk derived from any currency conversions may have a material effect on the results of its operations. The financial instruments impacted by a change in exchange rates include exposures to the above financial assets or liabilities denominated in nonfunctional currencies. Cash held by the Company in US dollars at September 30, 2024 was $ 159 175 If the US dollar to Canadian foreign exchange rate changed by 2% this would change the recorded net gain(loss) by $174 (September 30, 2023-$173)

Contingencies

Contingencies	12 Months Ended
	Sep. 30, 2024
Contingencies
Contingencies	21. Contingencies a. Refundable Ontario Investment Tax Credits On July 22, 2022, the Company received a Notice of Confirmation from the CRA relating to the 2014 and 2015 SRED reassessment for $ 299 302 b. Ministry of Energy On May 28, 2018, the Province of Ontario issued a claim against Electrovaya Corp. claiming $ 655 c. Other Contingencies In the normal course of business, the Company is party to business related claims. The potential outcomes related to existing matters faced by the Company are not determinable at this time. The Company intends to defend these actions, and management believes that the resolution of these matters will not have a material adverse effect on the Company’s financial condition.

Segment and Customer Reporting

Segment and Customer Reporting	12 Months Ended
	Sep. 30, 2024
Segment And Customer Reporting
Segment and Customer Reporting	22. Segment and Customer Reporting The Company develops, manufactures and markets power technology products. There is only a single segment applicable to the Company. Given the size and nature of the products produced, the Company’s sales are segregated based on large format batteries, with the remaining smaller product line categorized as “Other”. There has been no change in either the determination of the Company’s segments, or how segment performance is measured, from that described in the Company’s consolidated financial statements as at and for the year ended September 30, 2024. Schedule Of segment performance 2024 2023 Large format batteries 42,970 42,168 Other 1,645 1,891 Total of Large format batteries 44,615 44,059 Revenues can also be analyzed as follows based on the nature of the underlying deliverables: Schedule Of Revenues 2024 2023 Revenue with customers Sale of batteries and battery systems 42,970 42,168 Sale of services 983 216 Grant income Research grant 26 693 Others 636 982 Total of Revenue with customers 44,615 44,059 Revenues attributed to geographical regions based on the location of the customer were as follows: Schedule Of Revenues In geographical 2024 2023 Canada 1,655 1,258 United States 42,784 42,351 Others 176 450 44,615 44,059

Other payables

Other payables	12 Months Ended
	Sep. 30, 2024
Notes and other explanatory information [abstract]
Other payables	23. Other payables Technology Partnerships Canada (“TPC”) projects were long-term (up to 30 years) commencing with an R&D phase, followed by a benefits phase – the period in which a product, or a technology, could generate revenue for the Company. In such cases, repayments would flow back to the program according to the terms and conditions of the Company’s contribution agreement. In June 2018, the contribution agreement was amended and is included at its net present value in other payables. Further, in September 2024, the agreement was further amended with amended terms and conditions for the repayment of the debt with new payment schedule. Consequently, the old debt was de-recognised in the books of accounts and the new debt was introduced with first payment starting in July 2025 and final payment to be discharged in July 2031. The following table represents changes in the provision for repayments to Industry Canada. Schedule Of Other payables September 30, 2024 September 30, 2023 Opening balance 984 798 Interest accretion 490 186 Debt extinguishment (1,474 ) — Recognition of new debt 370 — Interest accretion on new debt 9 — Ending balance 379 984 Less: current portion of the provision (included in Trade and other payables) (36 ) (661 ) Ending balance of long-term portion 343 323 Following is the payment schedule for TPC: Schedule Of latest repayment Year Amount 2025 155 2026 132 2027 132 2028 132 2029 132 2030 132 2031 132

Income-tax

Income-tax	12 Months Ended
	Sep. 30, 2024
Notes and other explanatory information [abstract]
Income-tax	24. Income-tax The income tax recovery differs from the amount computed by applying the Canadian statutory income tax rate of 26.50 26.50 Schedule of Income Tax 2024 2023 Income (Loss) before income taxes (1,485 ) (1,479 ) Expected recovery of income taxes based on (394 ) (392 ) statutory rates Reduction in income tax recovery resulting from: Lower rate on manufacturing profits (9 ) (9 ) Other permanent differences 246 206 Deferred tax benefit not recognized 157 (484 ) Income tax recovery — (679 ) The components of deferred income taxes as at September 30, 2024 and 2023 are as follows: Schedule of components of deferred tax Opening, October 1, 2023 Recognized in P&L Recognized in OCI Closing, September 30, 2024 Deferred Tax Assets: Canadian non-capital loss carry forwards 602 (150 ) — 452 US net operating losses 408 (60 ) — 348 Deferred tax assets recognized 1,010 (210 ) — 800 Deferred Tax Liabilities Unrealized foreign exchange (11 ) 12 — 1 Property, plant and equipment (999 ) 198 — (801 ) (1,010 ) 210 — (800 ) Net Deferred tax asset (liability) — — — — Opening, October 1, 2022 Recognized in P&L Recognized in OCI Closing, September 30, 2023 Deferred Tax Assets Canadian non-capital loss carry forwards 47 555 — 602 US net operating losses — 408 — 408 Deferred tax assets recognized 47 963 — 1,010 Deferred Tax Liabilities Unrealized foreign exchange — (11 ) — (11 ) Property, plant and equipment (47 ) (273 ) (679 ) (999 ) (47 ) (284 ) (679 ) (1,010 ) Net Deferred tax asset (liability) — 679 (679 ) — In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the future tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of deferred taxable income during the year in which those temporary differences become deductible. Management considers projected future taxable income, uncertainties related to the industry in which the Company operates and tax planning strategies in making this assessment. The Company concluded that there is uncertainty regarding the future recoverability of Company’s deferred income tax assets in future periods. Therefore, deferred tax assets have not been recognized in the financial statements with respect to the following deductible temporary differences: Schedule Of operating deferred tax assets September 30, 2024 September 30, 2023 Canadian non-capital loss carry forwards 41,904 44,061 Canadian capital loss carry forwards 69 — US net operating losses 5,332 4,306 Property, plant and equipment — — Lease liabilities 2,342 2,727 Disallowed interest carry forwards 1,780 — Unclaimed research and development expenses 15,852 15,824 Non-refundable research and development credits 19,524 19,489 Other 1,121 1,343 87,924 87,750 ELECTROVAYA INC. The Company has Unrecognized losses that expire as early as 2025 as follows: Schedule of Unrecognized losses Year of expiry Canada USA 2025 — 1,422 2026 7,992 192 2027 3,405 678 2028 3,851 49 2029 — 356 2030 312 665 2031 — 1,083 2032 634 195 2033 995 149 2034 — 29 2035 2,200 — 2036 1,634 14 2037 2,179 2 2038 6,111 — 2039 2,194 — 2040 549 — 2041 5,106 — 2042 4,743 — 2043 — — 2044 — — Indefinite — 497 41,904 5,332

Subsequent events

Subsequent events	12 Months Ended
	Sep. 30, 2024
Subsequent Events
Subsequent events	25. Subsequent events In the month of November 2024, the Export-Import Bank of the United States (EXIM) approved a direct loan in the amount of $ 50.8

Material Accounting Policies (P

Material Accounting Policies (Policies)	12 Months Ended
	Sep. 30, 2024
Material Accounting Policies
Basis of consolidation	a. Basis of consolidation i. Subsidiaries These consolidated financial statements include direct and indirect subsidiaries, all of which are wholly owned. Any subsidiaries that are formed or acquired during the year are consolidated from their respective dates of formation or acquisition. Inter-company transactions and balances are eliminated on consolidation. Subsidiaries are entities controlled by the Company. The financial statements of subsidiaries are included in the consolidated financial statements from the date that control commences until the date that control ceases. The accounting policies of subsidiaries have been changed when necessary to align them with the policies adopted by the Company. All subsidiaries have the same reporting dates as their parent Company. ii. Transactions eliminated on consolidation Intra-company balances and transactions, and any unrealized income and expenses arising from intra-company transactions, are eliminated in preparing the consolidated financial statements.
Foreign currency	b. Foreign currency Each subsidiary of the Company maintains its accounting records in its functional currency. A Company’s functional currency is the currency of the principal economic environment in which it operates. i. Foreign currency transactions Transactions carried out in foreign currencies are translated using the exchange rate prevailing at the transaction date. Monetary assets and liabilities denominated in a foreign currency at the reporting date are translated at the exchange rate at that date. The foreign currency gain or loss on such monetary items is recognized as income or expense for the period. Non-monetary assets and liabilities denominated in a foreign currency are translated at the historical exchange rate prevailing at the transaction date. ii. Translation of financial statements of foreign operations The assets and liabilities of subsidiaries whose functional currency is not the U.S. dollar are translated into U.S. dollars at the exchange rate prevailing at the reporting date. The income and expenses of foreign operations whose functional currency is not the U.S. dollar are translated to U.S dollars at the exchange rate prevailing on the date of transaction. Foreign currency differences on translation are recognized in other comprehensive income in the cumulative translation account net of income tax. Foreign exchange gains or losses arising from a monetary item receivable from or payable to a foreign operation, the settlement of which is neither planned nor likely to occur in the foreseeable future and which in substance is considered to form part of the net investment in the foreign operation, are recognized in other comprehensive income in the foreign currency translation reserve.
Financial instruments	c. Financial instruments Recognition Financial assets and financial liabilities are recognized in the Company’s consolidated statement of financial position when the Company becomes a party to the contractual provisions of the instrument. On initial recognition, all financial assets and financial liabilities are recorded at fair value, net of attributable transaction costs, except for financial assets and liabilities classified as at fair value through profit or loss (‘FVTPL’). The directly attributable transactions costs of financial assets and liabilities as at FVTPL are expensed in the period in which they are incurred. Subsequent measurement of financial assets and liabilities depends on the classification of such assets and liabilities. Classification and Measurement The Company determines the classification of its financial instruments at initial recognition. Financial assets and financial liabilities are classified according to the following measurement categories: ● those to be measured subsequently at fair value either through profit or loss (“FVTPL”) or through other comprehensive income (“FVTOCI”); and, ● those to be measured subsequently at amortized cost. The classification and measurement of financial assets after initial recognition at fair value depends on the business model for managing the financial asset and the contractual terms of the cash flows. Financial assets that are held within a business model whose objective is to collect the contractual cash flows, and that have contractual cash flows that are solely payments of principal and interest on the principal outstanding, are generally measured at amortized cost at each subsequent reporting period. All other financial assets are measured at their fair values at each subsequent reporting period, with any changes recorded through FVTPL or through FVTOCI (which designation is made as an irrevocable election at the time of recognition). After initial recognition at fair value, financial liabilities are classified and measured at either: ● amortized cost. ● FVTPL, if the Company has made an irrevocable election at the time of recognition, or when required (for items such as instruments held for trading or derivatives); or, ● the Company reclassifies financial assets when and only when its business model for managing those assets changes. Financial liabilities are not reclassified. The Company’s financial assets consist of cash and cash equivalents, trade and other receivables and prepaid expenses, which are classified and subsequently measured at amortized cost. The Company’s financial liabilities consist of trade and other payables, working capital facilities, promissory notes, short term loans, lease liability, relief and recovery fund payable, and other payables, which are classified and measured at amortized cost using the effective interest method. Derivative liability is classified and measured at fair value through profit and loss. Interest expense is reported in profit or loss.
Cash equivalents	d. Cash equivalents Cash equivalents include short-term investments with original maturities of three months or less.
Inventories	e. Inventories Inventories are stated at the lower of cost and net realizable value. Cost of raw material is determined using the average cost method. Cost of semi-finished and finished goods are determined using the First in First out (FIFO) method. Cost includes all expenses directly attributable to the manufacturing process as well as appropriate portions of related production overheads. Net realizable value is the estimated selling price in the ordinary course of business less any applicable selling expenses.
Property, plant and equipment	f. Property, plant and equipment Recognition and measurement Items of property, plant and equipment (other than land and buildings) are measured at cost less accumulated depreciation and accumulated impairment losses. Cost includes the cost of material and labor and other costs directly attributable to bringing the asset to a working condition for its intended use. When significant components of an item of property, plant and equipment have different useful lives, they are accounted for as separate items of property, plant and equipment. Gains and losses on disposal of an item of property, plant and equipment are determined by comparing the proceeds from disposal with the carrying amount of property, plant and equipment, and are recognized net within profit or loss. The Company capitalizes borrowing costs directly attributable to the acquisition, construction or production of qualifying property, plant and equipment as part of the cost of that asset, if applicable. Capitalized borrowing costs are amortized over the useful life of the related asset. The Company adopted the revaluation method of accounting for the newly acquired building and land. Land and building measured using the revaluation method is initially measured at cost and subsequently carried at its revalued amount, being the fair value at the date of the revaluation less any subsequent accumulated depreciation and any accumulated impairment losses. Revaluations are made on an annual basis to ensure that the carrying amount does not differ significantly from fair value. Where the carrying amount of an asset increases as a result of revaluation, the increase is recognized in other comprehensive income or loss and accumulated in equity in revaluation surplus, unless the increase reverses a previously recognized impairment recorded through net income, in which case that portion of the increase is recognized in net income. Where the carrying amount of an asset decreases, the decrease is recognized in other comprehensive income to the extent of any balance existing in revaluation surplus in respect of the asset, with the remainder of the decrease recognized in profit or loss. Material residual value estimates and estimates of useful life are updated as required, but at least annually. Gains or losses arising on the disposal of property, plant and equipment are determined as the difference between the disposal proceeds and the carrying amounts of the assets and are recognized in profit or loss within “other income” or “other expenses. Subsequent costs The cost of replacing a part of an item of property, plant and equipment is recognized in the carrying amount of the item if it is probable that the future economic benefits embodied within the part will flow to the Company, and its cost can be measured reliably. The carrying amount of the replaced part is derecognized. Maintenance and repair costs are expensed as incurred, except where they serve to increase productivity or to prolong the useful life of an asset, in which case they are capitalized. Depreciation is provided on a straight-line basis over the estimated useful lives of the assets. The following useful lives are applied: Schedule Of Property, Plant and Equipment Useful Lives Item Life (in years) Leasehold improvements 3 Production equipment 2 15 Office furniture and equipment 2 5 Building 20 Right of use assets Over the lease term Depreciation methods, useful lives and residual values are reviewed at each reporting date and adjusted prospectively, if appropriate.
Leases	g. Leases Where the Company has entered a lease, the Company has recognized a right-of-use asset representing its rights to use the underlying assets and a lease liability representing its obligation to make lease payments. The right-of-use asset, where it relates to an operating lease, has been presented net of accumulated depreciation and is disclosed in the consolidated statement of financial position. The lease liability has been disclosed as a separate line item, allocated between current and non-current liabilities. The lease liability associated with all leases is measured at the present value of the expected lease payments at inception and discounted using the interest rate implicit in the lease. If the rate cannot be readily determined, the Company’s incremental borrowing rate is used to discount the lease liability. Judgement is required to determine the incremental borrowing rate.
Impairment	h. Impairment ● Financial assets The Company recognizes an allowance for credit losses equal to lifetime credit losses for trade and other receivables. None of these assets include a financing component. Significant receivable balances are assessed for impairment individually based on information specific to the customer. The remaining receivables are grouped, where possible, based on shared credit risk characteristics, and assessed for impairment collectively. The allowance assessment incorporates past experience, current and expected future conditions. ● Non-financial assets The carrying amounts of the Company’s non-financial assets, other than inventories and deferred tax assets are reviewed at each reporting date to determine whether there is any indication of impairment. If any such indication exists, then the asset’s recoverable amount is estimated. For intangible assets that are not yet available for use, the recoverable amount is estimated each year at the same time. An impairment loss is recognized if the carrying amount of an asset or its CGU exceeds its estimated recoverable amount. Impairment losses are recognized in profit or loss. Impairment losses recognized in respect of CGUs are allocated to the carrying amounts of the assets in the unit (group of units). In respect of other assets, impairment losses recognized in prior periods are assessed at each reporting date for any indications that the loss has decreased or no longer exists. An impairment loss is reversed if there has been a change in the estimates used to determine the recoverable amount. An impairment loss is reversed only to the extent that the asset’s carrying amount does not exceed the carrying amount that would have been determined, net of depreciation, if no impairment loss had been recognized.
Provisions	i. Provisions Legal Provisions are recognized for present legal or constructive obligations arising from past events when the amount can be reliably estimated, and it is probable that an outflow of resources will be required to settle an obligation. Provisions are measured at the estimated expenditure required to settle the present obligation, based on the most reliable evidence available at the reporting date, including the risks and uncertainties associated with the present obligation. Where there are a number of similar obligations, the likelihood that an outflow will be required in settlement is determined by considering the class of obligations as a whole. Provisions are discounted to their present values, where the time value of money is material. At the end of each reporting period, the Company evaluates the appropriateness of the remaining balances. Adjustments to the recorded amounts may be required to reflect actual experience or to reflect the current best estimate. In the normal course of operations, the Company may be subject to lawsuits, investigations and other claims, including environmental, labor, product, customer disputes and other matters. The ultimate outcome or actual cost of settlement may vary significantly from the original estimates. Material obligations that have not been recognized as provisions, as the outcome is not probable or the amount cannot be reliably estimated, are disclosed as contingent liabilities, unless the likelihood of outcome is remote.
Share-based payments	j. Share-based payments The Company accounts for all share-based payments to employees and non-employees using the fair value-based method of accounting. The Company measures the compensation cost of stock-based option awards to employees at the grant date using the Black-Scholes option pricing model to determine the fair value of the options. The share-based compensation cost of the options is recognized as stock-based compensation expense over the relevant vesting period of the stock options. Under the Company`s stock option plan, all options granted under the plan have a maximum term of 10 years and have an exercise price per share of not less than the market value of the Company’s common shares on the date of grant. The Board of Directors has the discretion to accelerate the vesting of options or stock appreciation rights granted under the plan in accordance with applicable laws and the rules and policies of any stock exchange on which the Company’s common shares are listed. The Company has an option plan whereby options are granted to employees and consultants as part of the Company’s incentive plans. Stock options vest in installments over the vesting period. Stock options typically vest one third each year over 3 years or immediately as approved by the Board. The Company treats each installment as a separate grant in determining stock-based compensation expense. The grant date fair value of options granted to employees is recognized as stock-based compensation expense, with a corresponding charge to contributed surplus, over the vesting period. The expense is adjusted to reflect the estimated number of options expected to vest at the end of the vesting period, adjusted for the estimated forfeitures during the period. Any cumulative adjustment prior to vesting is recognized in the current period. No adjustment is made to any expense recognized in the prior periods if share options ultimately exercised are different to that estimated on vesting. The fair value of options is measured using the Black-Scholes option pricing model. Measurement inputs include the price of Common shares on the measurement date, exercise price of the option, expected volatility (based on weighted average historic volatility), weighted average expected life of the option (based on historical experience and general option holder behavior), expected dividends, estimated forfeitures and the risk-free interest rate. Upon exercise of options, the proceeds received net of any directly attributable transaction costs up to the nominal value of the shares issued are allocated to share capital with any excess being recorded in retained earnings or deficit.
Income taxes	k. Income taxes Tax expense recognized in profit or loss comprises the sum of deferred tax and current tax not recognized in other comprehensive income or directly in equity. Current income tax assets and/or liabilities comprise those obligations to, or claims from, fiscal authorities relating to the current or prior reporting periods, that are unpaid at the reporting date. Current tax is payable on taxable profit, which differs from profit or loss in the financial statements. Calculation of current tax is based on tax rates and tax laws that have been enacted or substantively enacted by the end of the reporting period. Deferred income taxes are calculated using the liability method on temporary differences between the carrying amounts of assets and liabilities and their tax bases. However, deferred tax is not provided on the initial recognition of goodwill on the initial recognition of an asset or liability unless the related transaction is a business combination or affects tax or accounting profit or transactions that at the time of the transaction, does not give rise to equal taxable and deductible temporary differences. Deferred tax on temporary differences associated with investments in subsidiaries and joint ventures is not provided if reversal of these temporary differences can be controlled by the Company and it is probable that reversal will not occur in the foreseeable future. Deferred tax assets and liabilities are calculated, without discounting, at tax rates that are expected to apply to their respective period of realization, provided they are enacted or substantively enacted by the end of the reporting period. Deferred tax assets are recognized to the extent that it is probable that they will be able to be utilized against future taxable income, based on the Company’s forecast of future operating results which is adjusted for significant non-taxable income and expenses and specific limits to the use of any unused tax loss or credit. Deferred tax assets and liabilities are offset only when the Company has a right and intention to set off current tax assets and liabilities from the same taxation authority. Changes in deferred tax assets or liabilities are recognized as a component of tax income or expense in profit or loss, except where they relate to items that are recognized in other comprehensive income or directly in equity, in which case the related deferred tax is also recognized in other comprehensive income or equity, respectively. A valuation allowance is recorded against any deferred income tax asset if it is more likely than not that the asset will be realized.
Revenue	l. Revenue Revenue arises from the sale of goods and the rendering of services. It is measured by reference to the fair value of consideration received or receivable, excluding sales taxes, rebates, and trade discounts. The Company often enters sales transactions involving a range of the Company’s products and services, for example for the delivery of battery systems and related services. Sale of goods Sale of goods and services is recognized when the Company has transferred to the buyer the significant risks and rewards of ownership, generally when the customer has taken undisputed delivery of the goods and services. For contracts that permit the customer to return an item, revenue is recognized to the extent that it is highly probable that a significant reversal in the amount of cumulative revenue recognized will not occur. Therefore, the amount of revenue recognized is adjusted for expected returns, which are estimated based on the historical data for specific types of products. Advance payments by customers - Any advance receipts from customers are included in contract liabilities until the revenue recognition criteria is met. Warranty provision A provision for warranty costs is recorded on product sales at the time the sale is recognized. In establishing the warranty provision, management estimates the likelihood that products sold will experience warranty claims and the estimated cost to resolve claims received, taking into account the nature of the contract and past and projected experience with the products. Government Grants Government grants are recognized when there is reasonable assurance that the Company has met the requirements of the approved grant program and there is reasonable assurance that the grant will be received. Government grants that compensate for expenses already incurred are recognized in income on a systematic basis in the same year in which the expenses are incurred. Government grants for immediate financial support, with no future related costs, are recognized in income when receivable. Government grants that compensate the Company for the cost of an asset are recognized on a systematic basis over the useful life of the asset. Government grants consisting of investment tax credits are recorded as a reduction of the related expense or cost of the asset acquired. If a government grant becomes repayable, the repayment is treated as a change in estimate. Where the original grant related to income, the repayment is applied first against any related deferred government grant balance, and any excess as an expense. Where the original grant related to an asset, the repayment is treated as an increase to the carrying amount of the asset or as a reduction to the deferred government grant balance.
Research and development	m. Research and development Expenditure on research is recognized as an expense in the period in which it is incurred. Costs that are directly attributable to the development phase are recognized as intangible assets provided, they meet the following recognition requirements: ● completion of the intangible asset is technically feasible so that it will be available for use or sale. ● the Company intends to complete the intangible asset and use or sell it. ● the Company has the ability to use or sell the intangible asset. ● the intangible asset will generate probable future economic benefits. Among other things, this requires that there is a market for the output from the intangible asset or for the intangible asset itself, or, if it is to be used internally, the asset will be used in generating such benefits. ● there are adequate technical, financial and other resources to complete the development and to use or sell the intangible asset. ● the expenditure attributable to the intangible asset during its development can be measured reliably. Development costs not meeting these criteria for capitalization are expensed in profit or loss as incurred.
Finance income and expense, foreign currency gains and losses	n. Finance income and expense, foreign currency gains and losses Interest income is reported on an accrual basis using the effective interest method. Finance costs are comprised of interest expense on promissory notes, short term loans and working capital facilities. Borrowing costs that are not directly attributable to the acquisition, construction or production of a qualifying asset are recognized in profit or loss using the effective interest method. Foreign currency gains and losses are reported on a net basis.
Earnings per share (EPS)	o. Earnings per share (EPS) The Company presents basic and diluted earnings per share (“EPS”) data for its common shares. Basic EPS is calculated by dividing the profit or loss attributable to common shareholders of the Company by the weighted average number of common shares outstanding during the period. Diluted EPS is determined by adjusting the profit or loss attributable to common shareholders and the weighted average number of common shares outstanding, adjusted for own shares held, for the effects of all dilutive potential common shares, which comprise share options granted to employees. In a period of losses, the dilutive instruments comprising warrants and stock options are excluded for the determination of dilutive net loss per share because their effect is anti-dilutive.
Segment reporting	p. Segment reporting An operating segment is a component of the Company that engages in business activities from which it may earn revenues and incur expenses, including revenues and expenses that relate to transactions with any of the Company’s other components. All operating segments’ operating results are regularly reviewed by the Company’s chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and for which discrete financial information is available.

Material Accounting Policies (T

Material Accounting Policies (Tables)	12 Months Ended
	Sep. 30, 2024
Material Accounting Policies
Schedule Of Property, Plant and Equipment Useful Lives	Schedule Of Property, Plant and Equipment Useful Lives Item Life (in years) Leasehold improvements 3 Production equipment 2 15 Office furniture and equipment 2 5 Building 20 Right of use assets Over the lease term

Trade and Other Receivables (Ta

Trade and Other Receivables (Tables)	12 Months Ended
	Sep. 30, 2024
Trade And Other Receivables
Trade and Other Receivables	Trade and Other Receivables September 30, 2024 September 30, 2023 Trade receivables, gross 10,577 9,404 Expected credit losses (64 ) (257 ) Trade receivables 10,513 9,147 Other receivables 779 1,464 Trade and other receivables 11,292 10,611
Accounts receivable	Accounts receivable Particulars Current 31-60 61-90 91-120 >120 Total % 78.52 20.61 0.10 0.02 0.75 100 Gross Trade receivable 8,305 2,180 11 4 77 10,577 Particulars Current 31-60 61-90 91-180 181-365 >365 Total Trade receivable (net of specific provision) 8,305 2,180 11 4 29 48 10,577 Expected loss rate (%) 0.05 0.24 0.42 1.06 19.62 100 0.61 Expected loss provision 4 6 — — 6 48 64
Allowance for Credit Losses	Allowance for Credit Losses September 30, 2024 September 30, 2023 Beginning balance 257 54 Write off (244 ) — Allowance provided 51 203 Ending balance 64 257

Inventories (Tables)

Inventories (Tables)	12 Months Ended
	Sep. 30, 2024
Schedule Of Inventories
Schedule of Inventories	Schedule of Inventories September 30, 2024 September 30, 2023 Raw materials 8,433 6,553 Semi-finished 324 165 Finished goods 941 1,548 9,698 8,266

Revaluation of land and build_2

Revaluation of land and building (Tables)	12 Months Ended
	Sep. 30, 2024
Revaluation Of Land And Building
Schedule of Revaluation of Land And Building	Schedule of Revaluation of Land And Building High Low Market rent ($ sq ft) $ 7.10 $ 3.14 Capitalisation rate 13.70 % 9.50 % Sales ($ sq ft) $ 56.87 $ 35.41

Prepaid expenses (Tables)

Prepaid expenses (Tables)	12 Months Ended
	Sep. 30, 2024
Prepaid Expenses
Schedule of Prepaid Expenses	Schedule of Prepaid Expenses September 30, 2024 September 30, 2023 Prepaid expenses 612 486 Prepaid insurance 54 108 Prepaid purchases 6,981 5,403 Total 7,647 5,997

Property, plant and equipment (

Property, plant and equipment (Tables)	12 Months Ended
	Sep. 30, 2024
Property Plant And Equipment
Schedule Of Property, Plant and Equipment	Schedule Of Property, Plant and Equipment September 30, 2024 Land & Building Right of Use Leasehold Production Office Furniture & Equipment Total Gross carrying amount Balance beginning 7,700 3,197 76 1,712 73 12,758 Additions — — — 94 31 125 Exchange differences — 6 — 3 1 10 Balance ending 7,700 3,203 76 1,809 105 12,893 Depreciation and impairment Balance beginning (419 ) (1,127 ) (33 ) (970 ) (60 ) (2,609 ) Additions (374 ) (454 ) (15 ) (221 ) (11 ) (1,075 ) Exchange differences — (3 ) — (3 ) (1 ) (7 ) Balance ending (793 ) (1,584 ) (48 ) (1,194 ) (72 ) (3,691 ) Net Book Value ending 6,907 1,619 28 615 33 9,202 September 30, 2023 Land & Building Right of Use Leasehold Production Office Furniture & Equipment Total Gross carrying amount Balance beginning 5,105 2,582 39 1,240 56 9,022 Additions 2,595 573 37 452 16 3,673 Exchange differences — 42 — 20 1 63 Balance ending 7,700 3,197 76 1,712 73 12,758 Depreciation and impairment Balance beginning (104 ) (710 ) (20 ) (819 ) (55 ) (1,708 ) Additions (315 ) (406 ) (12 ) (138 ) (4 ) (875 ) Exchange differences — (11 ) (1 ) (13 ) (1 ) (26 ) Balance ending (419 ) (1,127 ) (33 ) (970 ) (60 ) (2,609 ) Net Book Value ending 7,281 2,070 43 742 13 10,149

Trade and Other Payables (Table

Trade and Other Payables (Tables)	12 Months Ended
	Sep. 30, 2024
Trade And Other Payables
Schedule of Trade and Other Payables	Schedule of Trade and Other Payables September 30, 2024 September 30, 2023 Trade payables 7,073 6,037 Accruals 1,732 1,197 Employee payables 655 1,186 Total 9,460 8,420
Schedule of Warranty Provisions	Schedule of Warranty Provisions September 30, 2024 September 30, 2023 Opening provision 250 — Warranty expenses during the year (672 ) (728 ) Additional provision during the year 1,494 978 Closing balance 1,072 250

Working Capital Facilities (Tab

Working Capital Facilities (Tables)	12 Months Ended
	Sep. 30, 2024
Working Capital Facilities
Schedule Of Revolving Credit Facility	Schedule Of Revolving Credit Facility September 30, 2024 September 30, 2023 Opening balance 11,821 11,635 Exchange difference 20 186 Payments made during the period (47,805 ) (34,184 ) Cash drawn during the period 52,247 34,184 Closing balance 16,283 11,821
Schedule Of finance cost and credited	Schedule Of finance cost and credited September 30, 2024 September 30, 2023 Promissory Note opening balance 1,026 4,363 Finance cost 37 126 Repayment of Promissory Note — (4,489 ) Repayment of Promissory Note (i) (507 ) — Finance cost paid with options (i) (37 ) — Promissory Note (ii) — 1,050 Repayment of Promissory Note (i) — (24 ) Promissory Note Ending balance $ 519 $ 1,026

Short term loans (Tables)

Short term loans (Tables)	12 Months Ended
	Sep. 30, 2024
Short Term Loans
Schedule Of Short term loans	Schedule Of Short term loans September 30, 2024 September 30, 2023 Vendor take back 1630 3,457
Schedule Of Short term VTB continuity	Schedule Of Short term VTB continuity The VTB continuity is as follows: Opening balance as at May 22, 2022 (Short term: $419. Long term: $3,826) 4,245 Repaid in year (150 ) Interest accretion 35 Closing balance as at September 30, 2022 (Short term: $673. Long term: $3,457) 4,130 Repaid in year (750 ) Interest accretion 77 Closing balance as at September 30, 2023 (Short term: $3,457. Long term: $nil) 3,457 Repaid in year (1,879 ) Interest accretion 52 Closing balance as at September 30, 2024 (Short term: $1,630 Long term : $nil) 1,630

Finance costs (Tables)

Finance costs (Tables)	12 Months Ended
	Sep. 30, 2024
Finance Costs
Schedule Of cash and non-cash finance costs	Schedule Of cash and non-cash finance costs September 30, 2024 September 30, 2023 Cash Non-Cash Total Cash Non-Cash Total Working capital facility 2,134 — 2,134 1,543 — 1,543 Issued to lender (note 15a) — 30 30 — 118 118 Shares issued to consultants — 169 169 — — — Promissory notes, accretion on promissory note and settlement fee on promissory note — 76 75 173 32 205 Interest on VTB loan (note 12) 96 52 148 77 — 77 Lease interest (note 14) — 349 348 — 380 380 Equity issuance costs 301 — 301 84 — 84 Warrant issuance costs — — — 134 — 134 Changes in FV of derivative warrants — (1,334 ) (1,334 ) — (361 ) (361 ) Accretion on government assistance — 48 48 — — — Accretion on government loans – TPC 2 443 446 — 294 294 2,533 (167 ) 2,366 2,011 463 2,474

Lease liability (Tables)

Lease liability (Tables)	12 Months Ended
	Sep. 30, 2024
Lease Liability
Schedule Of Lease liability	Schedule Of Lease liability September 30, 2024 September 30, 2023 Current 471 389 Non-current 1,871 2,338 Carrying amount - lease liability 2,342 2,727
Schedule Of Lease	Schedule Of Lease September 30, 2024 September 30, 2023 Interest on lease liabilities 349 380 Incremental borrowing rate at time of transition 14 % 14 % Cash outflow for the lease 735 707
Schedule Of minimum lease payments	Schedule Of minimum lease payments Year Amount 2025 760 2026 598 2027 555 2028 571 2029 588 2030 and beyond 148

Share capital (Tables)

Share capital (Tables)	12 Months Ended
	Sep. 30, 2024
Share Capital
Schedule Of Authorized and issued capital stock	Schedule Of Authorized and issued capital stock Common Shares Number Amount Balance, September 30, 2022 Note 29,437,372 $ 103,305 Issuance of shares (i) 3,508,680 7,167 Exercise of options Note 15(b) 6,800 8 Issuance of shares (ii) 14,414 59 Transfer from contributed surplus — 5 Exercise of options Note 15(b) 5,200 13 Transfer from contributed surplus — 11 Issuance of shares note (iii) 8,376 30 Issuance of shares note (iv) 10,443 30 Exercise of warrants Note 15(c) 841,499 3,004 Transfer from derivative liability — 1,409 Balance, September 30, 2023 33,832,784 115,041 Issuance of shares (v) 10,024 30 Issuance of shares (vi) 42,157 169 Transfer from contributed surplus — 501 Exercise of options Note 15(b) 252,700 667 Balance, September 30, 2024 34,137,665 116,408
Schedule Of Stock Options	Schedule Of Stock Options Note Number outstanding Weighted average exercise price Outstanding, September 30, 2022 3,727,588 2.30 Exercised Note 15(a) (6,800 ) 1.05 Exercised Note 15(a) (5,200 ) 2.55 Expired Note 15(a) (3,200 ) 2.60 Granted 1,060,000 4.04 Cancelled (58,000 ) 4.04 Outstanding, September 30, 2023 4,714,388 2.44 Exercised during the year Note 15(a) (252,700 ) 2.65 Expired during the year Note 15(a) (24,400 ) 2.87 Granted 443,000 3.42 Outstanding, September 30, 2024 4,880,288 2.52 Exercise price Number Outstanding Weighted average remaining life (years) Number exercisable Weighted average exercise price $ 3.46 (Cdn 4.68) 443,000 9.51 87,000 3.46 $ 3.96 (Cdn 5.35) 1,002,000 8.53 161,338 3.96 $ 2.11 (Cdn 2.85) 298,000 7.72 234,675 2.11 $ 4.26 (Cdn 5.75) 20,000 7.16 20,000 4.26 $ 3.70 (Cdn 5) 1,494,667 6.95 694,667 3.70 $ 2.44 (Cdn 3.3) 270,268 5.95 270,268 2.44 $ 1.11 (Cdn 1.5) 1,024,000 4.83 1,024,000 1.11 $ 1.04 (Cdn 1.4) 116,566 3.39 116,566 1.04 $ 4.51 (Cdn 6.1) 10,667 2.83 10,667 4.51 $ 7.88 (Cdn 10.65) 101,121 2.25 101,121 7.88 $ 2.92 (Cdn 3.95) 9,600 1.36 9,600 2.92 $ 2.55 (Cdn 3.45) 42,900 1.00 42,900 2.55 $ 3.37 (Cdn 4.55) 12,000 0.64 12,000 3.37 $ 2.41 (Cdn 3.25) 35,499 0.39 35,499 2.41 4,880,288 2,820,301 2.52
Schedule Of stock-based compensation costs	Schedule Of stock-based compensation costs Grant date April 05, 2024 No of options 443,000 Share price $ 3.44 Exercise price $ 3.44 Average expected life in years 10 Volatility 87.98 % Risk-free weighted interest rate 3.58 % Dividend yield — Fair-value of options granted $ 1,316 ii. The following table summarizes the assumptions used with the Black-Scholes valuation model for the determination of the stock-based compensation costs for the stock options granted during the year ended September 30, 2023: Grant date April 10, 2023 No of options 1,060,000 Share price $ 3.85 Exercise price $ 4.04 Average expected life in years 10 Volatility 79.30 % Risk-free weighted interest rate 2.92 % Dividend yield — Fair-value of options granted $ 4,282
Schedule Of Warrants	Details of Share Warrants Schedule Of Warrants Number Outstanding Exercise Price Outstanding, September 30, 2023 1,711,924 $ 2.38 Expired (291,924 ) $ 5.92 Outstanding, September 30, 2024 1,420,000 $ 2.38
Schedule Of Warrant continuity	Schedule Of Warrant continuity Units Fair Value Opening valuation as at Nov 9, 2022 1,754,340 3,259 Warrants exercised as at July 28, 2023 (841,499 ) (1,409 ) Fair value adjustment (361 ) Closing balance (September 30, 2023) 912,841 1,489 Fair value adjustment — (1,334 ) Closing balance (September 30, 2024) 912,841 155
Schedule Of Details of Compensation options	d. Details of Compensation options: Schedule Of Details of Compensation options Number Outstanding Exercise Price Outstanding, September 30, 2023 17,522 4.95 Expired during the year (17,522 ) 6.70 Outstanding, September 30, 2024 — —

Related Party Transactions (Tab

Related Party Transactions (Tables)	12 Months Ended
	Sep. 30, 2024
Related Party Transactions
Schedule of related party transactions Management compensation	Schedule of related party transactions Management compensation September 30, 2024 September 30, 2023 Salaries, bonus and other benefits 1,185 764 Share based compensation 969 1,089 Key Management Personnel Compensation 2,154 1,853
Schedule of accrued interest	Schedule of accrued interest September 30, 2024 September 30, 2023 Promissory Note (note 11(b)) 519 1,026

Change in Non-Cash Operating _2

Change in Non-Cash Operating Working Capital (Tables)	12 Months Ended
	Sep. 30, 2024
Change In Non-cash Operating Working Capital
Schedule Of Change in Non-Cash Operating Working Capital	Schedule Of Change in Non-Cash Operating Working Capital September 30, 2024 September 30, 2023 Trade and other receivables (732 ) (7,845 ) Inventories (1,418 ) (724 ) Prepaid expenses and other (1,693 ) (2,103 ) Trade and other payables 1,588 2,551 Total (2,255 ) (8,121 )

Financial Instruments (Tables)

Financial Instruments (Tables)	12 Months Ended
	Sep. 30, 2024
Financial Instruments
Schedule Of Warrant Fair Value	Schedule Of Warrant Fair Value Fair Value Level 1 Level 2 Level 3 Warrants 155 — 155 —
Schedule Of financial liabilities	The following are the undiscounted contractual maturities of significant financial liabilities and the total contractual obligations of the Company as at September 30, 2024: Schedule Of financial liabilities 2025 2026 2027 2028 2029 & beyond Total Trade and other payables 9,460 — — — — 9,460 Lease liability 760 598 555 571 588 3,072 Short term loan 1,630 — — — — 1,630 Promissory notes 519 — — — — 519 Working capital facility 16,283 — — — — 16,283 Other payable 211 188 208 218 610 1,435 Total financial liabilities 28,863 786 763 789 1,198 32,399 The following are the undiscounted contractual maturities of significant financial liabilities and the total contractual obligations of the Company as at September 30, 2023: 2024 2025 2026 2027 2028 & beyond Total Trade and other payables 8,429 — — — — 8,429 Lease liability 929 950 789 745 1,737 5,150 Short term loans 3,500 — — — — 3,500 Promissory note 1,026 — — — — 1,026 Working capital facility 11,821 — — — — 11,821 Other payable 1,365 490 215 56 38 2,164 Total financial liabilities 27,070 1,440 1,004 801 1,775 32,090

Segment and Customer Reporting

Segment and Customer Reporting (Tables)	12 Months Ended
	Sep. 30, 2024
Segment And Customer Reporting
Schedule Of segment performance	Schedule Of segment performance 2024 2023 Large format batteries 42,970 42,168 Other 1,645 1,891 Total of Large format batteries 44,615 44,059
Schedule Of Revenues	Schedule Of Revenues 2024 2023 Revenue with customers Sale of batteries and battery systems 42,970 42,168 Sale of services 983 216 Grant income Research grant 26 693 Others 636 982 Total of Revenue with customers 44,615 44,059
Schedule Of Revenues In geographical	Schedule Of Revenues In geographical 2024 2023 Canada 1,655 1,258 United States 42,784 42,351 Others 176 450 44,615 44,059

Other payables (Tables)

Other payables (Tables)	12 Months Ended
	Sep. 30, 2024
Notes and other explanatory information [abstract]
Schedule Of Other payables	Schedule Of Other payables September 30, 2024 September 30, 2023 Opening balance 984 798 Interest accretion 490 186 Debt extinguishment (1,474 ) — Recognition of new debt 370 — Interest accretion on new debt 9 — Ending balance 379 984 Less: current portion of the provision (included in Trade and other payables) (36 ) (661 ) Ending balance of long-term portion 343 323
Schedule Of latest repayment	Schedule Of latest repayment Year Amount 2025 155 2026 132 2027 132 2028 132 2029 132 2030 132 2031 132

Income-tax (Tables)

Income-tax (Tables)	12 Months Ended
	Sep. 30, 2024
Notes and other explanatory information [abstract]
Schedule of Income Tax	Schedule of Income Tax 2024 2023 Income (Loss) before income taxes (1,485 ) (1,479 ) Expected recovery of income taxes based on (394 ) (392 ) statutory rates Reduction in income tax recovery resulting from: Lower rate on manufacturing profits (9 ) (9 ) Other permanent differences 246 206 Deferred tax benefit not recognized 157 (484 ) Income tax recovery — (679 )
Schedule of components of deferred tax	Schedule of components of deferred tax Opening, October 1, 2023 Recognized in P&L Recognized in OCI Closing, September 30, 2024 Deferred Tax Assets: Canadian non-capital loss carry forwards 602 (150 ) — 452 US net operating losses 408 (60 ) — 348 Deferred tax assets recognized 1,010 (210 ) — 800 Deferred Tax Liabilities Unrealized foreign exchange (11 ) 12 — 1 Property, plant and equipment (999 ) 198 — (801 ) (1,010 ) 210 — (800 ) Net Deferred tax asset (liability) — — — — Opening, October 1, 2022 Recognized in P&L Recognized in OCI Closing, September 30, 2023 Deferred Tax Assets Canadian non-capital loss carry forwards 47 555 — 602 US net operating losses — 408 — 408 Deferred tax assets recognized 47 963 — 1,010 Deferred Tax Liabilities Unrealized foreign exchange — (11 ) — (11 ) Property, plant and equipment (47 ) (273 ) (679 ) (999 ) (47 ) (284 ) (679 ) (1,010 ) Net Deferred tax asset (liability) — 679 (679 ) —
Schedule Of operating deferred tax assets	Schedule Of operating deferred tax assets September 30, 2024 September 30, 2023 Canadian non-capital loss carry forwards 41,904 44,061 Canadian capital loss carry forwards 69 — US net operating losses 5,332 4,306 Property, plant and equipment — — Lease liabilities 2,342 2,727 Disallowed interest carry forwards 1,780 — Unclaimed research and development expenses 15,852 15,824 Non-refundable research and development credits 19,524 19,489 Other 1,121 1,343 87,924 87,750
Schedule of Unrecognized losses	Schedule of Unrecognized losses Year of expiry Canada USA 2025 — 1,422 2026 7,992 192 2027 3,405 678 2028 3,851 49 2029 — 356 2030 312 665 2031 — 1,083 2032 634 195 2033 995 149 2034 — 29 2035 2,200 — 2036 1,634 14 2037 2,179 2 2038 6,111 — 2039 2,194 — 2040 549 — 2041 5,106 — 2042 4,743 — 2043 — — 2044 — — Indefinite — 497 41,904 5,332

Basis of Presentation (Details

Basis of Presentation (Details Narrative) - USD ($)	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Basis Of Presentation
Company generated cash from operations	$ 1,040,000	$ 5,230,000
Working capital	890,000	710,000
Net loss	$ 1,490,000	$ 1,480,000

Schedule Of Property, Plant and

Schedule Of Property, Plant and Equipment Useful Lives (Details)	12 Months Ended
	Sep. 30, 2024
Leasehold Improvements [Member]
IfrsStatementLineItems [Line Items]
Estimated useful lives	3 years
Production Equipment [Member] | Bottom Of Range Unit [Member]
IfrsStatementLineItems [Line Items]
Estimated useful lives	2 years
Production [Member] | Top Of Range Unit [Member]
IfrsStatementLineItems [Line Items]
Estimated useful lives	15 years
Office Furniture And Equipment [Member] | Bottom Of Range Unit [Member]
IfrsStatementLineItems [Line Items]
Estimated useful lives	2 years
Office Furniture And Equipment [Member] | Top Of Range Unit [Member]
IfrsStatementLineItems [Line Items]
Estimated useful lives	5 years
Building [Member]
IfrsStatementLineItems [Line Items]
Estimated useful lives	20 years

Trade and Other Receivables (De

Trade and Other Receivables (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Sep. 30, 2023
Trade And Other Receivables
Trade receivables, gross	$ 10,577	$ 9,404
Expected credit losses	(64)	(257)
Trade receivables	10,513	9,147
Other receivables	779	1,464
Trade and other receivables	$ 11,292	$ 10,611

Accounts receivable (Details)

Accounts receivable (Details) $ in Thousands	12 Months Ended
	Sep. 30, 2024 USD ($)
IfrsStatementLineItems [Line Items]
Accounts receivable in percentage	1
Gross Trade receivable	$ 10,577
Trade receivable (net of specific provision)	$ 10,577
Expected loss rate	0.0061
Expected loss provision	$ 64
Currents [Member]
IfrsStatementLineItems [Line Items]
Accounts receivable in percentage	0.7852
Gross Trade receivable	$ 8,305
Trade receivable (net of specific provision)	$ 8,305
Expected loss rate	0.0005
Expected loss provision	$ 4
Thirtyone To Sixty [Member]
IfrsStatementLineItems [Line Items]
Accounts receivable in percentage	0.2061
Gross Trade receivable	$ 2,180
Trade receivable (net of specific provision)	$ 2,180
Expected loss rate	0.0024
Expected loss provision	$ 6
Sixtyone To Ninety [Member]
IfrsStatementLineItems [Line Items]
Accounts receivable in percentage	0.0010
Gross Trade receivable	$ 11
Trade receivable (net of specific provision)	$ 11
Expected loss rate	0.0042
Expected loss provision	$ 0
Ninetyone To Onehundred Twenty [Member]
IfrsStatementLineItems [Line Items]
Accounts receivable in percentage	0.0002
Gross Trade receivable	$ 4
Over One Hundred Twenty [Member]
IfrsStatementLineItems [Line Items]
Accounts receivable in percentage	0.0075
Gross Trade receivable	$ 77
Ninetyone To Onehundred Eighty [Member]
IfrsStatementLineItems [Line Items]
Trade receivable (net of specific provision)	$ 4
Expected loss rate	0.0106
Expected loss provision	$ 0
Onehundred Eighty One To Three Sixty Five [Member]
IfrsStatementLineItems [Line Items]
Trade receivable (net of specific provision)	$ 29
Expected loss rate	0.1962
Expected loss provision	$ 6
Greater Than Three Hundred Sixty Five [Member]
IfrsStatementLineItems [Line Items]
Trade receivable (net of specific provision)	$ 48
Expected loss rate	1
Expected loss provision	$ 48

Allowance for Credit Losses (De

Allowance for Credit Losses (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Trade And Other Receivables
Beginning balance	$ 257	$ 54
Write Off	(244)
Allowance Provided	51	203
Ending balance	$ 64	$ 257

Trade and Other Receivables (_2

Trade and Other Receivables (Details Narrative)	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Trade And Other Receivables
Accounts receivable Percentage	0.0077	0.0718

Schedule of Inventories (Detail

Schedule of Inventories (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Sep. 30, 2023
Schedule Of Inventories
Raw materials	$ 8,433	$ 6,553
Semi-finished	324	165
Finished goods	$ 941	$ 1,548

Inventories (Details Narrative)

Inventories (Details Narrative) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Schedule Of Inventories
Write-downs (reversals of write-downs) of inventories	$ 225	$ 162
Direct Manufacturing Costs Materials Expensed Amount	$ 29,250	$ 30,690

Schedule of Revaluation of Land

Schedule of Revaluation of Land And Building (Details)	12 Months Ended
	Sep. 30, 2024
IfrsStatementLineItems [Line Items]
Capitalization Rate	0.01
Top Of Ranges [Member]
IfrsStatementLineItems [Line Items]
Market Rent	7.10
Capitalization Rate	0.1370
Sales	56.87
Bottom Of Ranges [Member]
IfrsStatementLineItems [Line Items]
Market Rent	3.14
Capitalization Rate	0.0950
Sales	35.41

Revaluation of land and build_3

Revaluation of land and building (Details Narrative)	12 Months Ended
	Sep. 30, 2024 USD ($)
Revaluation Of Land And Building
Revaluation surplus	$ 2,600
Less tax	$ 679
Capitalization Rate	0.01
Change in the value of the land and building	$ 800

Schedule of Prepaid Expenses (D

Schedule of Prepaid Expenses (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Sep. 30, 2023
Prepaid Expenses
Prepaid expenses	$ 612	$ 486
Prepaid insurance	54	108
Prepaid purchases	6,981	5,403
Total	$ 7,647	$ 5,997

Schedule Of Property, Plant a_2

Schedule Of Property, Plant and Equipment (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
IfrsStatementLineItems [Line Items]
[Property, plant and equipment, gross carrying amount of fully depreciated assets still in use]	$ 12,758	$ 9,022
Additions during the year	125	3,673
Gross carrying amount Exchange differences	10	63
[Property, plant and equipment, gross carrying amount of fully depreciated assets still in use]	12,893	12,758
[Depreciation and impairment Balance at beginning]	(2,609)	(1,708)
Depreciation and impairment Additions	(1,075)	(875)
Depreciation and impairment Exchange differences	(7)	(26)
[Depreciation and impairment Balance at ending]	(3,691)	(2,609)
Property, plant and equipment (note 9)	9,202	10,149
Land And Buildings [Member]
IfrsStatementLineItems [Line Items]
[Property, plant and equipment, gross carrying amount of fully depreciated assets still in use]	7,700	5,105
Additions during the year	0	2,595
Gross carrying amount Exchange differences	0	0
[Property, plant and equipment, gross carrying amount of fully depreciated assets still in use]	7,700	7,700
[Depreciation and impairment Balance at beginning]	(419)	(104)
Depreciation and impairment Additions	(374)	(315)
Depreciation and impairment Exchange differences	0	0
[Depreciation and impairment Balance at ending]	(793)	(419)
Property, plant and equipment (note 9)	6,907	7,281
Rightofuse Asset [Member]
IfrsStatementLineItems [Line Items]
[Property, plant and equipment, gross carrying amount of fully depreciated assets still in use]	3,197	2,582
Additions during the year	0	573
Gross carrying amount Exchange differences	6	42
[Property, plant and equipment, gross carrying amount of fully depreciated assets still in use]	3,203	3,197
[Depreciation and impairment Balance at beginning]	(1,127)	(710)
Depreciation and impairment Additions	(454)	(406)
Depreciation and impairment Exchange differences	(3)	(11)
[Depreciation and impairment Balance at ending]	(1,584)	(1,127)
Property, plant and equipment (note 9)	1,619	2,070
Leasehold Improvements [Member]
IfrsStatementLineItems [Line Items]
[Property, plant and equipment, gross carrying amount of fully depreciated assets still in use]	76	39
Additions during the year	0	37
Gross carrying amount Exchange differences	0	0
[Property, plant and equipment, gross carrying amount of fully depreciated assets still in use]	76	76
[Depreciation and impairment Balance at beginning]	(33)	(20)
Depreciation and impairment Additions	(15)	(12)
Depreciation and impairment Exchange differences	0	(1)
[Depreciation and impairment Balance at ending]	(48)	(33)
Property, plant and equipment (note 9)	28	43
Production Equipment [Member]
IfrsStatementLineItems [Line Items]
[Property, plant and equipment, gross carrying amount of fully depreciated assets still in use]	1,712	1,240
Additions during the year	94	452
Gross carrying amount Exchange differences	3	20
[Property, plant and equipment, gross carrying amount of fully depreciated assets still in use]	1,809	1,712
[Depreciation and impairment Balance at beginning]	(970)	(819)
Depreciation and impairment Additions	(221)	(138)
Depreciation and impairment Exchange differences	(3)	(13)
[Depreciation and impairment Balance at ending]	(1,194)	(970)
Property, plant and equipment (note 9)	615	742
Office Furniture And Equipment [Member]
IfrsStatementLineItems [Line Items]
[Property, plant and equipment, gross carrying amount of fully depreciated assets still in use]	73	56
Additions during the year	31	16
Gross carrying amount Exchange differences	1	1
[Property, plant and equipment, gross carrying amount of fully depreciated assets still in use]	105	73
[Depreciation and impairment Balance at beginning]	(60)	(55)
Depreciation and impairment Additions	(11)	(4)
Depreciation and impairment Exchange differences	(1)	(1)
[Depreciation and impairment Balance at ending]	(72)	(60)
Property, plant and equipment (note 9)	$ 33	$ 13

Property, plant and equipment_2

Property, plant and equipment (Details Narrative)	Sep. 30, 2023 USD ($)
Property Plant And Equipment
Property, plant and equipment, revalued assets	$ 2,600,000

Schedule of Trade and Other Pay

Schedule of Trade and Other Payables (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Sep. 30, 2023
Trade And Other Payables
Trade payables	$ 7,073	$ 6,037
Accruals	1,732	1,197
Employee payables	655	1,186
Total	$ 9,460	$ 8,420

Schedule of Warranty Provisions

Schedule of Warranty Provisions (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Trade And Other Payables
Opening provision	$ 250
Warranty expenses during the year	(672)	(728)
Additional provision during the year	1,494	978
Closing balance	$ 1,072	$ 250

Schedule Of Revolving Credit Fa

Schedule Of Revolving Credit Facility (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Working Capital Facilities
Opening balance	$ 11,821	$ 11,635
Exchange difference	20	186
Payments made during the period	(47,805)	(34,184)
Cash drawn during the period	52,247	34,184
Closing balance	$ 16,283	$ 11,821

Schedule Of finance cost and cr

Schedule Of finance cost and credited (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Working Capital Facilities
Promissory Note opening balance	$ 1,026	$ 4,363
Finance cost	37	126
Repayment of Promissory Note		(4,489)
Repayment of Promissory Note(i)	(507)
Finance cost paid with options(i)	(37)
Promissory Note(ii) issued		1,050
Repayment of Promissory Note(i)		(24)
Promissory Note Ending balance	$ 519	$ 1,026

Working Capital Facilities (Det

Working Capital Facilities (Details Narrative) - USD ($)		12 Months Ended
	Feb. 12, 2024	Sep. 30, 2024	Sep. 29, 2023	Jun. 30, 2023	Dec. 20, 2022	Nov. 09, 2022
Working Capital Facilities
Maximum funds available		$ 16,280,000
Stock issued			10,443	8,376	14,414	1,754,340
CommitmentFees	$ 303

Schedule Of Short term loans (D

Schedule Of Short term loans (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Short Term Loans
Vendor take back	$ 1,630	$ 3,457

Schedule Of Short term VTB cont

Schedule Of Short term VTB continuity (Details) - USD ($) $ in Thousands	4 Months Ended	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2024	Sep. 30, 2023
Short Term Loans
Repaid in year	$ 4,245	$ 3,457	$ 4,130
Repaid in year	(150)	(1,879)	(750)
Interest accretion	$ 35	52	$ 77
Vendor Take Back Ending Balance		$ 1,630

Short term loans (Details Narra

Short term loans (Details Narrative)	12 Months Ended
	Sep. 30, 2024 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2019 USD ($)	Sep. 30, 2017 USD ($)
Short Term Loans
Short term loan principal amount			$ 218	$ 364
Interest on loan per annum				0.018
Interest Description			The loans had interest at 2% per month and carried a commitment fee of 5
Vendor Take Back payment	$ 1,630,000
[Vendor Take Back]		$ 3,450,000

Schedule Of cash and non-cash f

Schedule Of cash and non-cash finance costs (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
IfrsStatementLineItems [Line Items]
Working capital facility	$ 2,134	$ 1,543
Issued to lender	30	118
Shares Iissued to Consultants	169
Settlement fee on promissory notel facility	75	205
Interest on VTB loan	148	77
Lease interest	348	380
Equity issuance costs	301	84
Warrant issuance costs		134
Changes in FV of derivative warrants	(1,334)	(361)
Accretion on Government Assistance	48
Accretion on Government Loans	446	294
Finance costs	2,366	2,474
Cash [Member]
IfrsStatementLineItems [Line Items]
Working capital facility	2,134	1,543
Issued to lender
Shares Iissued to Consultants
Settlement fee on promissory notel facility		173
Interest on VTB loan	96	77
Lease interest
Equity issuance costs	301	84
Warrant issuance costs		134
Changes in FV of derivative warrants
Accretion on Government Assistance
Accretion on Government Loans	2
Finance costs	2,533	2,011
Non Cash [Member]
IfrsStatementLineItems [Line Items]
Working capital facility
Issued to lender	30	118
Shares Iissued to Consultants	169
Settlement fee on promissory notel facility	76	32
Interest on VTB loan	52
Lease interest	349	380
Equity issuance costs
Warrant issuance costs
Changes in FV of derivative warrants	(1,334)	(361)
Accretion on Government Assistance	48
Accretion on Government Loans	443	294
Finance costs	$ (167)	$ 463

Schedule Of Lease liability (De

Schedule Of Lease liability (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Sep. 30, 2023
Lease Liability
Current	$ 471	$ 389
Non-current	1,871	2,338
Carrying amount - lease liability	$ 2,342	$ 2,727

Schedule Of Lease (Details)

Schedule Of Lease (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Lease Liability
Interest on lease liabilities	$ 349	$ 380
Incremental borrowing rate at time of transition	14%	14%
Cash outflow for the lease	$ 735	$ 707

Schedule Of minimum lease payme

Schedule Of minimum lease payments (Details) $ in Thousands	12 Months Ended
	Sep. 30, 2024 USD ($)
Lease Liability
2025	$ 760
2026	598
2027	555
2028	571
2029	588
2030 and beyond	$ 148

Lease liability (Details Narrat

Lease liability (Details Narrative) - USD ($) $ in Thousands	Sep. 30, 2024	Sep. 30, 2023
IfrsStatementLineItems [Line Items]
lease liability	$ 3,072	$ 5,150
Lease Monthly Rent First Year [Member]
IfrsStatementLineItems [Line Items]
lease liability	25,625
Lease Monthly Rent Second Year [Member]
IfrsStatementLineItems [Line Items]
lease liability	26,265
Lease Monthly Rent Third Year [Member]
IfrsStatementLineItems [Line Items]
lease liability	$ 26,922

Schedule Of Authorized and issu

Schedule Of Authorized and issued capital stock (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
IfrsStatementLineItems [Line Items]
Balance, September 30, 2023	$ 115,041
Balance, September 30, 2024	116,408	$ 115,041
Common Shares [Member]
IfrsStatementLineItems [Line Items]
Balance, September 30, 2023	$ 115,041	$ 103,305
Balance at beginning (in shares)	33,832,784	29,437,372
Issuance of shares		$ 7,167
Issuance of shares (in shares)		3,508,680
Exercise of options	$ 667	$ 8
Excercise of options (in shares)	252,700	6,800
Issuance of shares		$ 59
Issuance of shares (in shares)		14,414
Transfer from contributed surplus	$ 501	$ 5
Exercise of options		$ 13
Excercise of options (in shares)		5,200
Transfer from contributed surplus		$ 11
Issuance of shares note		$ 30
Issuance of share note (in shares)		8,376
Issuance of shares note		$ 30
Issuance of shares note (in shares)		10,443
Exercise of warrants		$ 3,004
Excercise of warrants (in shares)		841,499
Transfer from derivative liability		$ 1,409
Issuance of shares	$ 30
Issuance of shares (in shares)	10,024
Issuance of shares	$ 169
Issuance of shares (in shares)	42,157
Balance, September 30, 2024	$ 116,408	$ 115,041
Balance at ending (in shares)	34,137,665	33,832,784

Schedule Of Stock Options (Deta

Schedule Of Stock Options (Details) - $ / shares	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
IfrsStatementLineItems [Line Items]
Balance at beginning (in shares)	17,522
Balance at ending (in shares)		17,522
[custom:NumberOfShareOneOutstanding-0]	4,880,288
Number Of Exercisable	2,820,301
Stock Options [Member]
IfrsStatementLineItems [Line Items]
Balance at beginning (in shares)	4,714,388	3,727,588
Balance at beginning	$ 2.44	$ 2.30
Excercised (in shares)		(6,800)
Exercised during the year	$ 2.65	$ 1.05
Excercised (in shares)		(5,200)
Exercised		$ 2.55
Expired (in shares)		(3,200)
Expired		$ 2.60
Granted (in shares)	443,000	1,060,000
Granted	$ 3.42	$ 4.04
Cancelled (in shares)		(58,000)
Weighted Average Exercise Price Cancelled Or Expired		$ 4.04
Excercised during the year (in shares)	(252,700)
Expired during the year (in shares)	(24,400)
Expired during the year	$ 2.87
Balance at ending (in shares)	4,880,288	4,714,388
Balance at ending	$ 2.52	$ 2.44
Stock Options1 [Member]
IfrsStatementLineItems [Line Items]
[custom:NumberOfShareOneOutstanding-0]	443,000
Weighted Average Remaining Contractual Life Of Outstanding Share Options	9 years 6 months 3 days
Number Of Exercisable	87,000
Stock Options2 [Member]
IfrsStatementLineItems [Line Items]
[custom:NumberOfShareOneOutstanding-0]	1,002,000
Weighted Average Remaining Contractual Life Of Outstanding Share Options	8 years 6 months 10 days
Number Of Exercisable	161,338
Stock Options3 [Member]
IfrsStatementLineItems [Line Items]
[custom:NumberOfShareOneOutstanding-0]	298,000
Weighted Average Remaining Contractual Life Of Outstanding Share Options	7 years 8 months 19 days
Number Of Exercisable	234,675
Stock Options4 [Member]
IfrsStatementLineItems [Line Items]
[custom:NumberOfShareOneOutstanding-0]	20,000
Weighted Average Remaining Contractual Life Of Outstanding Share Options	7 years 1 month 28 days
Number Of Exercisable	20,000
Stock Options5 [Member]
IfrsStatementLineItems [Line Items]
[custom:NumberOfShareOneOutstanding-0]	1,494,667
Weighted Average Remaining Contractual Life Of Outstanding Share Options	6 years 11 months 12 days
Number Of Exercisable	694,667
Stock Options6 [Member]
IfrsStatementLineItems [Line Items]
[custom:NumberOfShareOneOutstanding-0]	270,268
Weighted Average Remaining Contractual Life Of Outstanding Share Options	5 years 11 months 12 days
Number Of Exercisable	270,268
Stock Options7 [Member]
IfrsStatementLineItems [Line Items]
[custom:NumberOfShareOneOutstanding-0]	1,024,000
Weighted Average Remaining Contractual Life Of Outstanding Share Options	4 years 9 months 29 days
Number Of Exercisable	1,024,000
Stock Options8 [Member]
IfrsStatementLineItems [Line Items]
[custom:NumberOfShareOneOutstanding-0]	116,566
Weighted Average Remaining Contractual Life Of Outstanding Share Options	3 years 4 months 20 days
Number Of Exercisable	116,566
Stock Options9 [Member]
IfrsStatementLineItems [Line Items]
[custom:NumberOfShareOneOutstanding-0]	10,667
Weighted Average Remaining Contractual Life Of Outstanding Share Options	2 years 9 months 29 days
Number Of Exercisable	10,667
Stock Options10 [Member]
IfrsStatementLineItems [Line Items]
[custom:NumberOfShareOneOutstanding-0]	101,121
Weighted Average Remaining Contractual Life Of Outstanding Share Options	2 years 3 months
Number Of Exercisable	101,121
Stock Options11 [Member]
IfrsStatementLineItems [Line Items]
[custom:NumberOfShareOneOutstanding-0]	9,600
Weighted Average Remaining Contractual Life Of Outstanding Share Options	1 year 4 months 9 days
Number Of Exercisable	9,600
Stock Options12 [Member]
IfrsStatementLineItems [Line Items]
[custom:NumberOfShareOneOutstanding-0]	42,900
Weighted Average Remaining Contractual Life Of Outstanding Share Options	1 year
Number Of Exercisable	42,900
Stock Options13 [Member]
IfrsStatementLineItems [Line Items]
[custom:NumberOfShareOneOutstanding-0]	12,000
Weighted Average Remaining Contractual Life Of Outstanding Share Options	7 months 20 days
Number Of Exercisable	12,000
Stock Options14 [Member]
IfrsStatementLineItems [Line Items]
[custom:NumberOfShareOneOutstanding-0]	35,499
Weighted Average Remaining Contractual Life Of Outstanding Share Options	4 months 20 days
Number Of Exercisable	35,499

Schedule Of stock-based compens

Schedule Of stock-based compensation costs (Details) - USD ($) $ / shares in Units, $ in Thousands	Apr. 05, 2024	Apr. 10, 2023
Share Capital
No of options	443,000	1,060,000
Share price	$ 3.44	$ 3.85
Exercise price	$ 3.44	$ 4.04
Average Expected Life In Years	10 years	10 years
Volatility	87.98%	79.30%
Risk-free weighted interest rate	3.58%	2.92%
Fair-value of options granted	$ 1,316	$ 4,282

Schedule Of Warrants (Details)

Schedule Of Warrants (Details)	12 Months Ended
	Sep. 30, 2024 $ / shares shares
IfrsStatementLineItems [Line Items]
Balance at beginning (in shares)	17,522
Excercise Price Expired During The Year | $ / shares	$ 6.70
Balance at ending (in shares)
Details Of Share Warrants [Member]
IfrsStatementLineItems [Line Items]
Balance at beginning (in shares)	1,711,924
[custom:ExcercisePrice-1] | $ / shares	$ 2.38
Increase (decrease) in number of shares outstanding	(291,924)
Excercise Price Expired During The Year | $ / shares	$ 5.92
Balance at ending (in shares)	1,420,000
[custom:ExcercisePrice-2] | $ / shares	$ 2.38

Schedule Of Warrant continuity

Schedule Of Warrant continuity (Details) - Warrant Continuity [Member] - USD ($) $ in Thousands	11 Months Ended	12 Months Ended
	Sep. 30, 2023	Sep. 30, 2024
IfrsStatementLineItems [Line Items]
Warrant Continuity	1,754,340	912,841
Reimbursement rights related to defined benefit obligation, at fair value at beginning of period	$ 3,259	$ 1,489
Warrant Exercised	(841,499,000)
Fair Value Warrant Exercised	$ (1,409)
Fair Value Adjustment	$ (361)	$ (1,334)
Warrant Continuity	912,841	912,841
Reimbursement rights related to defined benefit obligation, at fair value at end of period	$ 1,489	$ 155

Schedule Of Details of Compensa

Schedule Of Details of Compensation options (Details)	12 Months Ended
	Sep. 30, 2024 $ / shares shares
Share Capital
Balance at beginning (in shares) | shares	17,522
[custom:ExcercisePriceOne-1] | $ / shares	$ 4.95
Increase Decrease In Number Of Shares Outstandings | shares	(17,522)
Excercise Price Expired During The Year | $ / shares	$ 6.70
Balance at ending (in shares) | shares
[custom:ExcercisePriceOne-2] | $ / shares

Share capital (Details Narrativ

Share capital (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands			1 Months Ended					12 Months Ended
	Apr. 05, 2024	Apr. 10, 2023	Dec. 31, 2023	Sep. 29, 2023	Jun. 30, 2023	Mar. 25, 2022	Dec. 17, 2021	Sep. 30, 2024	Sep. 30, 2023	Dec. 20, 2022	Nov. 09, 2022
IfrsStatementLineItems [Line Items]
Number Of Non Brokerdprivate Placement Units								3,508,680
Share Issue Price Per Share									$ 4.23
Number of shares issued				10,443	8,376					14,414	1,754,340
Description Related To Warrant Exercise								The warrant exercise price would be adjusted from $5.30 to $4.70
Finance costs								$ 2,366	$ 2,474
Description About Reverse Stock Split			reducing the number of outstanding Common Shares from approximately 164.86 million to approximately 32.97 million
Description Related To Reduce Number Of Outstanding Share							reducing the number of outstanding options from approximately 23.5 million to 4.7 million
Description Related To Stock Option Plan						Stock Option Plan to increase the maximum number of common shares issuable upon the exercise of stock options thereunder from 4,600,000 to 6,000,000		Stock Option Plan to increase the maximum number of common shares issuable upon the exercise of stock options thereunder from 3,020,000 to 4,600,000
Description Of Stock Based Compensation								options exercised, the share price at the time of exercise was between CDN $2.47-$4.06. Total stock-based compensation expense recognized during the year ended September 30, 2024 was $2,155 (2023: $1,167)
Expected volatility, share options granted	87.98%	79.30%
Derivatives Warrants [Member]
IfrsStatementLineItems [Line Items]
Number Of Derivative Warrants								912,841
Description Of Risk Free Interest Rate Share Options Grante								2.94%
Expected volatility, share options granted								52.72%
Description Related To Derivative Warrants								reducing the number of outstanding warrants from approximately 13.1 million to 2.6 million. A 10% of change in any assumption would result in the change in derivative warrant liability between $(51) (September 30, 2023: ($417)) and $(2) (September 30, 2023: $393)
Share Capital [Member]
IfrsStatementLineItems [Line Items]
Share Issue Price Per Share			$ 3.99	$ 3.83						$ 5.55
Number of shares issued			10,024	10,443	8,376					14,414,000
Finance costs			$ 40	$ 40	$ 40

Schedule of related party trans

Schedule of related party transactions Management compensation (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Related Party Transactions
Salaries, bonus and other benefits	$ 1,185	$ 764
Share based compensation	969	1,089
Key Management Personnel Compensation	$ 2,154	$ 1,853

Schedule of accrued interest (D

Schedule of accrued interest (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Related Party Transactions
Promissory Note (note 11(b))	$ 519	$ 1,026

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)	1 Months Ended	12 Months Ended
	Apr. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
IfrsStatementLineItems [Line Items]
Stock based compensation expense		$ 2,155,000	$ 1,167,000
Stock based compensation expense	$ 512,000
Stock based compensation expense			260,000
Purchased land and buildings			2,700,000	$ 5,100,000
Deposit				600,000
Promissory note payable				4,400,000
Transaction costs				$ 105,000
Purchase price			500,000
Share-Based Payment Arrangement, Tranche One [Member]
IfrsStatementLineItems [Line Items]
Option granted		700,000
Vested option		200,000
Stock based compensation expense		$ 456,000	256,000
Share-Based Payment Arrangement, Tranche Two [Member]
IfrsStatementLineItems [Line Items]
Vested option		300,000
Share-Based Payment Arrangement, Tranche Three [Member]
IfrsStatementLineItems [Line Items]
Option granted		900,000
Vested option		300,000
Stock based compensation expense			$ 248,000

Schedule Of Change in Non-Cash

Schedule Of Change in Non-Cash Operating Working Capital (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Sep. 30, 2023
Change In Non-cash Operating Working Capital
Trade and other receivables	$ (732)	$ (7,845)
Inventories	(1,418)	(724)
Prepaid expenses and other	(1,693)	(2,103)
Trade and other payables	1,588	2,551
Total	$ (2,255)	$ (8,121)

Relief and Recovery Fund Paya_2

Relief and Recovery Fund Payable (Details Narrative)	12 Months Ended
	Sep. 30, 2021 USD ($)
Relief And Recovery Fund Payable
Amount received from fund	$ 300
Repayment Term	5 years

Government Assistance (Details

Government Assistance (Details Narrative)	12 Months Ended
	Sep. 30, 2024 USD ($)
Government Assistance
Research and Development	$ 133

Schedule Of Warrant Fair Value

Schedule Of Warrant Fair Value (Details) $ in Thousands	12 Months Ended
	Sep. 30, 2024 USD ($)
IfrsStatementLineItems [Line Items]
Warrants	$ 155
Level 1 Of Fair Values Hierarchy [Member]
IfrsStatementLineItems [Line Items]
Warrants	0
Level 2 Of Fair Values Hierarchy [Member]
IfrsStatementLineItems [Line Items]
Warrants	155
Level 3 Of Fair Values Hierarchy [Member]
IfrsStatementLineItems [Line Items]
Warrants	$ 0

Schedule Of financial liabiliti

Schedule Of financial liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Sep. 30, 2023
IfrsStatementLineItems [Line Items]
Trade and other payables	$ 9,460	$ 8,429
Lease liability	3,072	5,150
Short term loans	1,630	3,500
Promissory note	519	1,026
Working capital facility	16,283	11,821
Other payable	1,435	2,164
Total financial liabilities	32,399	32,090
Financial Liabilities Twenty Twenty Five [Member]
IfrsStatementLineItems [Line Items]
Trade and other payables	9,460
Lease liability	760	950
Short term loans	1,630
Promissory note	519
Working capital facility	16,283
Other payable	211	490
Total financial liabilities	28,863	1,440
Financial Liabilities Twenty Twenty Six [Member]
IfrsStatementLineItems [Line Items]
Trade and other payables
Lease liability	598	789
Short term loans
Promissory note
Working capital facility
Other payable	188	215
Total financial liabilities	786	1,004
Financial Liabilities Twenty Twenty Seven [Member]
IfrsStatementLineItems [Line Items]
Trade and other payables
Lease liability	555	745
Short term loans
Promissory note
Working capital facility
Other payable	208	56
Total financial liabilities	763	801
Financial Liabilities Twenty Twenty Eight [Member]
IfrsStatementLineItems [Line Items]
Trade and other payables
Lease liability	571	1,737
Short term loans
Promissory note
Working capital facility
Other payable	218	38
Total financial liabilities	789	1,775
Financial Liabilities Twenty Twenty Nine [Member]
IfrsStatementLineItems [Line Items]
Trade and other payables
Lease liability	588
Short term loans
Promissory note
Working capital facility
Other payable	610
Total financial liabilities	$ 1,198
Financial Liabilities Twenty Twenty Four [Member]
IfrsStatementLineItems [Line Items]
Trade and other payables		8,429
Lease liability		929
Short term loans		3,500
Promissory note		1,026
Working capital facility		11,821
Other payable		1,365
Total financial liabilities		$ 27,070

Financial Instruments (Details

Financial Instruments (Details Narrative) - USD ($)			12 Months Ended
	Apr. 05, 2024	Apr. 10, 2023	Sep. 30, 2024	Sep. 30, 2023
IfrsStatementLineItems [Line Items]
Volatility	87.98%	79.30%
Risk-free weighted interest rate	3.58%	2.92%
Long-term deposit				$ 459
Long-term deposit				134
Long-term deposit				325
Description related to credit risk and concentration risk			Accounts receivables are recorded at the invoiced amount, do not bear interest, and do not require collateral. For the year ended September 30, 2024, two customers accounted for $38.9 million or 87.21% of revenue (2023 one customer accounted for $42 million or 94%). As of September 30, 2024, two customers accounted for 96 % of accounts receivable (2023 one customer accounted for 85%).
[Cash]			$ 159,000	$ 175,000
Description related to foreign exchange rate			Canadian foreign exchange rate changed by 2% this would change the recorded net gain(loss) by $174 (September 30, 2023-$173)
Derivatives Liabilities [Member]
IfrsStatementLineItems [Line Items]
Fair Value of Warrants			$ 3,300,000
Expected life of warrants			3 years
Volatility			85.58%
Risk-free weighted interest rate			3.87%
Annual dividend yield			0%
Key Valuation Inputs Andassumptions [Member]
IfrsStatementLineItems [Line Items]
Expected life of warrants			1 year 1 month 6 days
Volatility			52.72%
Risk-free weighted interest rate			2.94%
Annual dividend yield			0%

Contingencies (Details Narrativ

Contingencies (Details Narrative) - USD ($)	1 Months Ended
	May 22, 2018	Sep. 30, 2024	Sep. 30, 2023
IfrsStatementLineItems [Line Items]
Dispute regarding funding and fulfilment	$ 655
July Twenty Two Two Thousand Twenty Two [Member]
IfrsStatementLineItems [Line Items]
Estimated financial effect of contingent liabilities		$ 299	$ 302

Schedule Of segment performance

Schedule Of segment performance (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Segment And Customer Reporting
Large format batteries	$ 42,970	$ 42,168
Other	1,645	1,891
Total of Large format batteries	$ 44,615	$ 44,059

Schedule Of Revenues (Details)

Schedule Of Revenues (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Segment And Customer Reporting
Sale of batteries and battery systems	$ 42,970	$ 42,168
Sale of services	983	216
Research grant	26	693
Others	636	982
Total of Revenue with customers	$ 44,615	$ 44,059

Schedule Of Revenues In geograp

Schedule Of Revenues In geographical (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
IfrsStatementLineItems [Line Items]
[Others]	$ 176	$ 450
Total Of Revenues Attributed	44,615	44,059
Canada [Member]
IfrsStatementLineItems [Line Items]
Revenues attributed	1,655	1,258
United States [Member]
IfrsStatementLineItems [Line Items]
Revenues attributed	$ 42,784	$ 42,351

Schedule Of Other payables (Det

Schedule Of Other payables (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Sep. 30, 2023
Notes and other explanatory information [abstract]
Opening balance	$ 984	$ 798
Interest accretion	490	186
Debt extinguishment	(1,474)
Recognition of new debt	370
Interest accretion on new debt	9
Ending balance	379	984
Less: current portion of the provision (included in Trade and other payables)	(36)	(661)
Ending balance of long-term portion	$ 343	$ 323

Schedule Of latest repayment (D

Schedule Of latest repayment (Details) $ in Thousands	12 Months Ended
	Sep. 30, 2024 USD ($)
Notes and other explanatory information [abstract]
2025	$ 155
2026	132
2027	132
2028	132
2029	132
2030	132
2031	$ 132

Schedule of Income Tax (Details

Schedule of Income Tax (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Notes and other explanatory information [abstract]
Income (Loss) before income taxes	$ (1,485)	$ (1,479)
Expected recovery of income taxes based on	(394)	(392)
Lower rate on manufacturing profits	(9)	(9)
Other permanent differences	246	206
Deferred tax benefit not recognized	157	(484)
Income tax recovery		$ (679)

Schedule of components of defer

Schedule of components of deferred tax (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
IfrsStatementLineItems [Line Items]
Deferred tax assets recognized in profit (loss)	$ (210)	$ 963
Income tax relating to components of other comprehensive income		(679)
Net Deferred tax asset (liability) Recognized in profit (loss)		1,010	$ 47
Deferred Tax Assets Recognized Ending Balance	800	1,010
Deferred Tax Liabilities Ending Balance	(800)	(1,010)
Deferred Tax Liabilities Recognized Beginning Balance		(1,010)	(47)
Net Deferred Tax Asset Liability Beginning Balance
Net Deferred tax asset (liability) Recognized in profit (loss)		679
Net Deferred Tax Asset Liability Recognized In Oci		(679)
Net Deferred Tax Asset Liability Ending Balance
Deferred Tax Assets Recognized Beginning			47
[custom:DeferredTaxLiabilitiesRecognizedInProfitLoss]		(284)
Property, Plant and Equipment [Member]
IfrsStatementLineItems [Line Items]
Deferred tax assets recognized in profit (loss)	198	(273)
Income tax relating to components of other comprehensive income		(679)
[custom:UsNetOperatingLossesBeginningBalance-0]		408
Deferred Tax Liabilities Beginning Balance		(999)	(47)
Deferred Tax Liabilities Ending Balance	(801)	(999)
Unrealized Foreign Exchange [Member]
IfrsStatementLineItems [Line Items]
Canadian non-capital loss carry forwards		602
Deferred tax assets recognized in profit (loss)	12	(11)
Income tax relating to components of other comprehensive income
[custom:CanadianNoncapitalLossCarryForwardsEndingBalance-0]	452
Deferred Tax Liabilities Beginning Balance		(11)
Deferred Tax Liabilities Ending Balance	1	(11)
Canadian Non Capital Loss Carry Forwards [Member]
IfrsStatementLineItems [Line Items]
Deferred tax assets recognized in profit (loss)	(150)	555
Income tax relating to components of other comprehensive income
Deferred tax assets		602
U Snet Operating Losses [Member]
IfrsStatementLineItems [Line Items]
Deferred tax assets recognized in profit (loss)	(60)	408
Deferred tax assets	$ 348	$ 408

Schedule Of operating deferred

Schedule Of operating deferred tax assets (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Sep. 30, 2023
Notes and other explanatory information [abstract]
Canadian non-capital loss carry forwards	$ 41,904	$ 44,061
Canadian capital loss carry forwards	69
US net operating losses	5,332	4,306
Property, plant and equipment
Lease liabilities	2,342	2,727
Disallowed interest carry forwards	1,780
Unclaimed research and development expenses	15,852	15,824
Non-refundable research and development credits	19,524	19,489
Other	1,121	1,343
	$ 87,924	$ 87,750

Schedule of Unrecognized losses

Schedule of Unrecognized losses (Details) $ in Thousands	Sep. 30, 2024 USD ($)
Canada [Member]
IfrsStatementLineItems [Line Items]
2025
2026	7,992
2027	3,405
2028	3,851
2029
2030	312
2031
2032	634
2033	995
2034
2035	2,200
2036	1,634
2037	2,179
2038	6,111
2039	2,194
2040	549
2041	5,106
2042	4,743
2043
2044
Indefinite
	41,904
U S A [Member]
IfrsStatementLineItems [Line Items]
2025	1,422
2026	192
2027	678
2028	49
2029	356
2030	665
2031	1,083
2032	195
2033	149
2034	29
2035
2036	14
2037	2
2038
2039
2040
2041
2042
2043
2044
Indefinite	497
	$ 5,332

Income-tax (Details Narrative)

Income-tax (Details Narrative)	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Canadian [Member]
IfrsStatementLineItems [Line Items]
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	26.50%	26.50%

Subsequent events (Details Narr

Subsequent events (Details Narrative)	Sep. 30, 2024 USD ($)
Subsequent Events
Non-current loans and receivables	$ 5,080,000